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The lymphatic system maintains body fluid homeostasis, lipid absorption, and 
immune surveillance by transporting fluid, macromolecules, and cells back to the 
circulatory system. Disrupted lymphatic integrity or pumping causes numerous severe 
diseases, including lymphedema and inflammatory disorders. Calcium (Ca2+) release-
activated Ca2+ (CRAC) channels mediate the ubiquitous store-operated Ca2+ entry 
(SOCE) and are essential for various cellular processes (e.g., T cell activation, mast cell 
degranulation, and endothelial cell proliferation). However, the role of CRAC channels 
in the lymphatic system remains unclear. In this dissertation we addressed the function 
of CRAC channels in cultured lymphatic endothelial cells (LECs) responding to fluid 
shear stress (FSS) and histamine. In the model of FSS stimulation, we described the Ca2+ 
dynamics triggered by FSS in LECs and determined the necessity of CRAC channels, 
formed by Orai1 and STIM1 proteins, in the Ca2+ signaling utilizing pharmacological 
blockers and RNA interference (RNAi). By using confocal imaging and RNA-
sequencing (RNA-Seq), we further found that the activation of nuclear factor of 
activated T-cells (NFAT) and transcriptional reprogramming downstream of FSS were 
also dependent on CRAC channels. Our quantitative PCR (qPCR) and enzyme-linked 
immunosorbent assay (ELISA) data also showed that blocking CRAC channels 
abolished the regulation of interleukin-8 (IL-8) secretion by FSS, indicating that CRAC 
channels are required in FSS-induced cytokine modulation. In addition, we studied the 




discovered that histamine evoked the intracellular Ca2+ store release through H1 
receptors (H1R) and phospholipase C (PLC). The subsequent sustained Ca2+ entry from 
the extracellular solution triggered by histamine was mediated by CRAC channels. We 
also examined the lymphatic endothelial barrier function after histamine stimulation and 
found that the hyperpermeability and VE-cadherin disruption caused by histamine was 
attenuated by CRAC channel blockers. Moreover, the knockdown of CRAC channels 
diminished the inflammatory cytokine expression after histamine stimulation in LECs. In 
summary, this study demonstrated the essential role of CRAC channels in both 
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1. INTRODUCTION  
 
1.1. The lymphatic system 
The lymphatic system is composed of lymphatic organs, lymphatic vessels, and 
the lymph transported in the vessels (1). The major functions of the lymphatic system 
include body fluid homeostasis, immune surveillance, and dietary lipid absorption (2). 
The lymph is formed in the initial lymphatics that are blind-ended lymphatic capillaries 
constructed of one layer of partially overlapping LECs usually without a continuous 
basement membrane or lymphatic muscle coverage (3). Compared to post-capillary 
venules, the initial lymphatics have a higher permeability to the body fluid containing 
macromolecules and cells due to the loose “button-like” junctional structures (4). This 
unique endothelial alignment in the initial lymphatics allows temporary openings 
between two adjacent LECs, forming “primary lymphatic valves” in the vessel wall to 
allow fluid entrance while preventing fluid exit (5, 6). Therefore, the initial lymphatics 
can take up the excess fluid accumulated in the interstitial space when the interstitial 
pressure is higher than the pressure inside the vessel, and transport the lymph to the 
collecting lymphatic vessels (2, 7). Similarly, the initial lymphatics in the small intestine, 
also known as lacteals, collect dietary lipid contained in the chylomicrons via the 
primary lymphatic valves and move them to the bloodstream (8). 
The collecting lymphatic vessels, compared to the initial lymphatics, have tighter 
endothelial junctions, luminal lymphatic valves, and a significant amount of lymphatic 




cells, with the contractile properties of both cardiac muscle and vascular smooth muscle 
cells, provide the intrinsic force to drive the lymph forward with spontaneous and 
rhythmical contractions (5, 10-12). The lymphatic valves, formed by LECs and 
extracellular matrix, divide collecting lymphatic vessels into many segments, termed 
lymphangions, and minimize lymph backflow between the lymphangion contractions 
(13). With this phasic pumping of collecting lymphatic vessels, the lymph is transported 
to the lymphatic trunk through a series of lymph nodes (5). 
The transport of antigens and immune cells from the peripheral tissues to the 
lymph nodes is critical to initiate adaptive immune responses and maintain immune 
surveillance (2). Most pathogens (e.g., soluble factors, bacteria and viruses) are collected 
by the initial lymphatics through the primary lymphatic valves when the intercellular 
gaps are opened (6). The soluble antigens are transported quickly to the draining lymph 
node conduit system and processed by resident dendritic cells (DCs) in the lymph node 
(14). The larger pathogens are captured by the lymph node sinus macrophages and 
presented to the B cells (15, 16). Meanwhile, DCs carrying antigens and some T cells 
migrate from the interstitial spaces to the lymphatics via a chemotactic response to 
CCL21, an important chemokine produced by LECs that interacts with the CCR7 on the 
surface of migrating immune cells (17-19). These immune cells are carried by lymph 
flow to the lymph node B cell or T cell areas for immune surveillance and leave the 
lymph node for further immune responses (20, 21). After exiting the last set of lymph 
nodes, the lymph is collected by the lymphatic trunks, drained into lymphatic ducts, and 





1.2. The lymphatics in lymphedema and inflammation 
The lymphatic system plays a critical role in many human diseases, including 
lymphedema, metabolic syndrome, inflammation, and cancer metastasis, corresponding 
to its major functions in maintaining fluid homeostasis, lipid uptake, and immune 
surveillance (2, 22). Lymphedema is characterized as a set of chronic and debilitating 
pathological conditions with regional swelling of the extremities caused by the 
accumulation of protein-rich fluid in the interstitial area (23). Primary lymphedema is 
caused by hereditary genetic defects while secondary lymphedema results predominantly 
from compromised lymph drainage following infection, surgery, or radiotherapy (24). 
For example, surgery or radiotherapy to treat breast cancer is a common cause of 
secondary lymphedema in the arm on the treated side of the body due to the lymph node 
dissection and lymphatic vessel disruption during the treatments (25, 26). Although 
several techniques (e.g., lymphoscintigraphy and optical frequency domain imaging) 
have been developed to image lymph transport in vivo, curable treatments for 
lymphedema are still lacking (27, 28). In animal models, some studies have shown the 
possibility of improving lymphangiogenesis by applying vascular endothelial growth 
factor C or D (VEGF-C or D) to promote the proliferation of LECs (29-33). However, 
considering the effects of VEGFs, whether this approach could rebuild the lymphatic 
network and restore lymphatic pumping without aggravating the vessel leakage or 




As an essential part of immune surveillance, the lymphatic system is involved in 
various inflammatory conditions as well as cancer metastasis, but the exact functions and 
mechanisms are still under debate (2). Inflammation is a self-defensive process during 
infection, injury, and other insults, involving the accumulation of leukocytes and 
cytokines in the damaged tissues (34). In acute inflammations, such as in infections or 
wounds, VEGF-A and -C are highly expressed by several cell types (e.g., activated 
macrophages and DCs) in the injured tissue, promoting lymphangiogenesis to facilitate 
fluid removal and leukocyte migration (35, 36). On the other hand, the lymphatic 
dysfunction is also associated with pathological conditions accompanying chronic 
inflammation. For example, lymphatic obstruction or dysfunction is closely linked to the 
pathogenesis of inflammatory bowel disease (IBD) (37). It has been suggested that 
failure to clear the lipid, leukocytes, and inflammatory mediators out of the gut by the 
lymphatic system contributes to the intestinal inflammation and immune disturbance in 
IBD (11, 38, 39). 
 
1.3. The role of LECs in regulating lymphatic pumping 
Lymphatic pumping, including both extrinsic and intrinsic pumping, is essential 
to propel lymph against the pressure gradient and gravity back to the bloodstream in the 
human body (11). The extrinsic pumping exists mostly in the tissues or organs with self-
compression activities (e.g., heart and skeletal muscle) where the tissue/organ 
compression and expansion drives lymph forward; on the other hand, intrinsic pumping 




force to drive the lymph flow in most tissues (5). The lymphatic pumping frequency and 
amplitude is dynamically regulated by multiple factors, including neural stimuli and 
mechanical forces (12, 40, 41). One major mechanical force modulating lymphatic 
contractile function is fluid shear stress (FSS), which is extremely variable and 
bidirectional in most regions of the lymphatic system (42). Both frequency and 
amplitude of lymphatic pumping are inhibited when a high flow is imposed on an 
isolated rat lymphatic vessel, which is mostly abolished by removing LECs or blocking  
nitric oxide (NO) production, indicating a critical role of LECs in this process (43). 
Lymphatic endothelium, a fundamental layer of the lymphatic vessels, is 
subjected to lymph flow directly and provides the necessary signals to modulate 
lymphatic pumping (44). The endothelium-derived NO is synthesized from L-arginine 
by the endothelial nitric oxide synthase (eNOS), a Ca2+/calmodulin-dependent enzyme 
(45, 46). In blood vessels, NO is regarded as a vasodilator that also inhibits smooth 
muscle proliferation, platelet aggregation, and leukocyte activation (47-51). In the 
lymphatics, NO has a similar function in endothelium-dependent vessel relaxation (52). 
More importantly, lymphatic contractions upregulate the production of NO in a 
frequency-dependent manner, while the NO, in return, slows down the contractions to 
reduce lymph flow (43, 52-55). Although the detailed mechanism of this LEC-dependent 
regulation of lymphatic pumping is still unclear, FSS is considered one of the most 
predominant factors triggering this process (56). In addition, histamine is also reported 




derived histamine in flow-mediated lymphatic relaxation, suggesting more potential 
signaling pathways contributing to the control of lymphatic pumping (57, 58).  
 
1.4. Vascular and endothelial responses to histamine 
Histamine is an inflammatory mediator commonly used to study cellular or tissue 
responses to inflammation in cultured cells or in animals (59). Histamine binds four 
subtypes of G protein-coupled receptors (GPCRs), H1R – H4R, after being produced 
predominantly by mast cells and basophils in humans (60). Histamine is known to alter 
the contraction and permeability of both blood vessels and lymphatic vessels, thereby 
causing vasodilation, enhanced lymphatic phasic contractility and edema in 
inflammatory regions (57, 59, 61). Meanwhile, histamine is also involved in FSS-
dependent lymphatic vessel relaxation, indicating its unique function in the lymphatics 
(58). It is well established that histamine enhances intracellular Ca2+ concentration 
([Ca2+]i), modulates the cell skeleton, and increases permeability in blood endothelial 
cells (BECs) (62). The hyperpermeability is largely caused by the disruption of 
intercellular junctions, including adherens and tight junctions (61, 63-65). One well-
accepted mechanism behind these junctional gaps is that histamine triggers Ca2+-
dependent retraction of BECs via the interaction between F-actin and myosin, thereby 
breaking adherens and tight junctions temporarily (62, 66, 67). In this process, the Rho 
family of GTPases (especially RhoA) is considered to be involved in the formation of 
stress fibers and cell retraction (67-69). In addition, histamine also stimulates the 




histamine in vasodilation and relaxation (70). Furthermore, histamine increases the 
expression of inflammatory cytokines, interleukin (IL)-6 and IL-8, in BECs as a 
relatively chronic effect (> 4 hours after stimulation), suggesting its involvement in the 
late stages of inflammatory reactions (71, 72).  
As discussed above, Ca2+ signaling is essential for many histamine responses 
(e.g., cell retraction and NO production) in BECs. Histamine activates the PLC family 
through the Gq subunit of H1R and hydrolyzes the phospholipid phosphatidylinositol 
4,5-bisphosphate (PIP2) to generate inositol 1,4,5-trisphosphate (IP3) and diacyl glycerol 
(DAG) (60, 73). IP3 functions as a second messenger to release the endoplasmic 
reticulum (ER) Ca2+ store after binding to its receptor (IP3R) on the ER membrane, and 
elicits downstream Ca2+ signaling in BECs (60, 73). 
 
1.5. Ca2+ release-activated Ca2+ (CRAC) channel 
Ca2+ is one of the most ubiquitous second messengers transducing the stimuli 
from the cell surface receptors to downstream cellular functions (74). The Ca2+ signaling 
profile, both spatial and temporal, is critical for many fundamental cellular processes, for 
example, heart contraction, immune cell activation, and neural transmission (75). There 
are two major sources to elevate [Ca2+]i rapidly and activate downstream Ca2+ 
responsive proteins: the intracellular Ca2+ store and the extracellular environment (76). 
Since the intracellular Ca2+ store release is normally transient and needs to be refilled 
after each opening, the Ca2+ entry from the extracellular environment via Ca2+ permeable 




Ca2+ signal refilling the ER Ca2+ store after its depletion by introducing Ca2+ influx 
across the plasma membrane (78). One extensively studied channel mediating SOCE is 
the CRAC channel, a highly Ca2+-selective channel with low single-channel conductance 
(79, 80).  
The CRAC channel is typically activated by the IP3R-elicited ER Ca2+ depletion 
following GPCR activation and PLC-catalyzed IP3 production (79). The 
electrophysiological properties of the CRAC current (ICRAC) have been studied in 
multiple cell types (78). It has a signature inwardly rectifying current–voltage 
relationship with an extremely high selectivity of Ca2+ over monovalent cations (about 
1000:1); on the other hand, the CRAC channel shows a very low single-channel 
conductance (< 1 pS) and is regulated by both fast (milliseconds) and slow (seconds to 
tens of seconds) Ca2+-dependent inactivation (81, 82). The CRAC channel has little 
voltage-dependent gating and is not responsive to most voltage-gated/L-type Ca2+ 
channel blockers, indicating its distinction from the L-type Ca2+ channels (83).  
The molecular identity of the CRAC channel was discovered by several groups 
in 2005 and 2006: stromal interaction molecule (STIM) proteins on the ER membrane 
and Orai proteins on the plasma membrane (PM) (84-92). Orai1 has two paralogues, 
Orai2 and Orai3, while STIM1 has one paralogue, STIM2, in humans (83).  
Human Orai1, with 301 amino acids and four transmembrane (TM) domains, 
forms the CRAC channel on the PM (79). The TM1 domain of Orai1 was shown to form 
the channel pore with a glutamate residue (E106) serving as the Ca2+ binding site (87-89, 




one Ca2+-selective pore, and further functional analysis in vitro confirmed this finding, 
suggesting that the Orai1 channel functions as a hexamer (93-96).  
Human STIM1 is a single-pass TM protein containing 685 amino acids, 
primarily located on the ER membrane with its N-terminus inside the ER lumen and the 
C-terminus facing the cytosol, sensing the Ca2+ inside the ER via its low-affinity EF 
hand calcium-binding motif (97). It also contains a sterile alpha motif (SAM) at the N-
terminus, which can be unfolded when the Ca2+ is dissociated from the EF hand motif 
upon ER Ca2+ depletion (98). This unfolding process comes with the oligomerization 
and translocation of STIM1 to the ER-PM junctions where STIM1 proteins cluster into 
large puncta (99, 100). The C-terminus of STIM1 consists of three coiled-coil domains 
(CC1, CC2, and CC3), an inhibitory domain, serine/proline and lysine rich regions, and 
a TRIP domain (77). STIM1 interacts with Orai1 through a CRAC activation domain 
(CAD) within the coiled-coil domains and gate Orai1 channels to allow influx of 
extracellular Ca2+ into the puncta area (101, 102). 
The Orai2 and Orai3 proteins also have four TM domains like Orai1 and elicit 
store-operated Ca2+ currents like ICRAC when overexpressed with STIM1 (103). 
However, their kinetics of channel activation and inactivation, as well as their ion 
selectivity and pharmacological sensitivity are different from Orai1 channels (104, 105). 
Moreover, the expression patterns of Orai1, 2, and 3 are not identical. Orai1 and Orai3 
are found in most examined human and murine tissues, while Orai2 is limited to some 
species-dependent specific tissues (lung and spleen in both human and mouse, kidney in 




Orai2 and Orai3 channels are defined when overexpressed in vitro, the functional study 
of endogenous Orai2 and Orai3 is still limited (77); hence, their functional necessity and 
distinctions from Orai1 channels remain to be explored.  
STIM2 is widely and robustly expressed in most human and murine tissues and 
cells with STIM1 (97). STIM2 can form heteropolymers with STIM1 and its 
homopolymers can also activate Orai1 channels in both a store-dependent and store-
independent manner in vitro, possibly because it does not require complete ER depletion 
to gate CRAC channels (107). Furthermore, STIM2 knockout in T cells showed 
intriguing results indicating that the initial ICRAC was preserved with weakened long-term 
Ca2+ signaling and downstream nuclear factor activation (108). Until now, the specific 
role of STIM2 and its functional relationship with STIM1 are still under debate. 
 
1.6. Pharmacological inhibition and activation of the CRAC channels 
With the discovery of the CRAC channel and its functions, many 
pharmacological tools have been developed to modulate its activities. Inhibitors of 
CRAC channels were applied to study SOCE much earlier than the identification of 
Orai1 and STIM1 proteins, in which Gd3+ and La3+ are the most widely used ones (109). 
These trivalent lanthanides, Gd3+ and La3+, block the CRAC channels pore completely at 
the sub-micromolar levels (110). In comparation, other Ca2+ channels require higher 
concentrations for total blockage; for example, TRPC channels need 100 µM of Gd3+ for 
complete blockage (76). Another famous inhibitor of CRAC channels is 2-




Orai2 channels transiently and then block their functions at high concentrations (25-100 
µM) (104, 111, 112). The mechanism is partially explained by the prevention of STIM1 
puncta formation at the ER-PM junctions (113). There is another CRAC channel 
inhibitor, ML-9, sharing a similar mechanism with 2-APB by impairing STIM1 
movement. ML-9 was discovered as a myosin light chain kinase (MLCK) inhibitor, but 
its inhibition of CRAC channels is not MLCK dependent (114, 115). Many other 
compounds or drugs have been developed in several labs and by pharmaceutical 
companies to block CRAC channels, including BTP1-3, analogs of APB, Nocodazole, 
Synta66, SKF-96365, NPPB, and so on (116). All of these compounds showed high 
CRAC channel blocking potency, but their specificity and side effects on other Ca2+ 
channels need more attention and research.  
Unlike the variety of CRAC channel inhibitors, the knowledge regarding the 
activators of CRAC channels is still very limited. Since the CRAC channel is store-
operated, any drug, that releases ER Ca2+ or prevents ER refilling, can activate the 
CRAC channels indirectly through intracellular store depletion (76). However, 2-APB is 
the only small-molecule compound with well-defined characteristics of direct CRAC 
channel gating so far (76). As described above, although 2-APB is a CRAC channel 
inhibitor at high concentrations (>25 µM); it promotes Orai1 channel activity in several 
cell types and gates Orai3 channels strongly and consistently at lower concentrations 
(<20 µM) (113). Interestingly, the 2-APB-induced Orai3 current is not identical to the 
native store-operated Orai3 current with regard to Ca2+ selectivity (117, 118). 




unique pharmacological mechanism underlying 2-APB-induced CRAC channel activity 
(113). After the intense study of Orai1 and STIM1 proteins in the last decade, a few 
macromolecular factors have been reported to gate CRAC channels directly. Especially, 
a peptide shown to be the Orai1-interactive region of STIM1 can gate Orai1 channels 
regardless of store depletion (119-122).  
Overall, many groups and companies are studying drugs that modulate CRAC 
channel activities and functions. Although the mechanisms and pharmacological 
properties of many drugs have not been elucidated in vivo yet, studies of their actions 
have provided insight for the development of other potential drugs to treat CRAC-related 
diseases in humans. 
 
1.7. The functions of CRAC channels in diseases 
Disrupted CRAC channel functions due to loss-of-function (LOF) Orai1 
mutations have been found to cause severe combined immunodeficiency (SCID) in 
several families. The first family identified with a loss of SOCE in their T cells, B cells, 
and fibroblasts had a missense mutation (asparagine 91 to tryptophan, R91W) at a 
preserved site located in the first TM domain of Orai1 protein (123, 124). The R91W 
mutation does not alter the Orai1 expression or localization on the PM but leads to the 
absence of SOCE and ICRAC through Orai1 channels (90). The T cells from these patients 
are normally developed; however, cell activation is markedly compromised and cytokine 
production is deficient (123, 124). Further analysis revealed that the abolished Orai1 




and NFAT translocation into the nucleus (123, 125). Another family with similar 
syndromes was diagnosed to carry a frame-shift mutation of Orai1 (Orai1-A88EfsX25) 
at the A88 position causing a premature termination of protein transcription and 
translation (126). The patients carrying the Orai1-A88EfsX25 mutation lack complete 
and functional Orai1 proteins in their cells, and therefore, lose the normal activation and 
function of T cells (127). One more patient suffering from immunodeficiency was 
reported with Orai1 protein absent on the cell membrane and the SOCE severely 
diminished in multiple cell types, including T cells and B cells (128). In this patient, two 
missense mutations were identified in Orai1, A103E and L194P, at the TM1 and TM3 
regions, respectively (126). These two mutations destabilize the endogenous Orai1 
protein expression, weaken the normal activation of immune cells, and lead to 
immunodeficiency in the patient (126).  
On the other hand, LOF mutations in STIM1 are also associated with immune 
dysfunctions. One family suffering from immune disorders had significantly decreased 
expression of STIM1 protein and was diagnosed to have an insertion in the STIM1 gene 
(STIM1-E128RfsX9) that causes premature termination of protein transcription and 
translation (129). In this case, the endogenous STIM2 is not able to rescue the SOCE or 
ICRAC in the patients; nevertheless, ectopic expression of STIM1 or STIM2 can 
successfully rescue the absent in vitro SOCE in cells extracted from these patients (129). 
These STIM1-deficient patients have lymphoproliferative autoimmune diseases in 




condition, suggesting a critical role of STIM1 in maintaining immune tolerance in 
humans. 
Besides immune disorders, patients with compromised CRAC channel function 
also suffer from non-immune-related diseases, including but not limited to myopathy 
and anhydrotic ectodermal dysplasia (EDA). The muscular hypotonia is observed in 
most Orai1- or STIM1-deficient patients, and is characterized as muscle fatigue, 
respiratory muscle weakness, reduced walking distance, and impaired head control (126, 
127, 129). The muscle biopsy of an Orai1-deficient patient reveals significantly 
unbalanced type I and type II fibers in the skeletal muscle cells, indicating the necessity 
of Orai1 function in muscle fiber differentiation (126). However, the muscle biopsy of 
STIM1-deficient patients does not show similar results (129). Moreover, STIM1-
deficient patients and two surviving Orai1-deficient patients display notable EDA, 
characterized as defects in dental enamel and sweat gland development (126, 129).  
Recently, gain-of-function (GOF) mutations in STIM1 and Orai1 have been 
found to cause tubular aggregate myopathy (TAM), Stormorken syndrome, and York 
platelet syndrome in human patients (130-133). Most of the mutations in TAM patients 
(STIM1-H72Q, N80T, G81D, D84E, D84G, S88G, L96V, F108I, F108L, H109 N, 
H109R, I115F) are observed in the STIM1 luminal EF-hand region, with two more 
mutations (STIM1-R304W and R304Q) discovered in the CC2 domain of STIM1 (134-
139). These GOF STIM1 mutations cause oligomerization of STIM1 proteins regardless 
of endoplasmic/sarcoplasmic reticulum (ER/SR) Ca2+ depletion and, thereby, recruit and 




share a similar mechanism of disrupting Ca2+ binding or destabilizing interaction with 
the SAM domain (130, 137). The R304W/Q mutation in the CC2 domain is believed to 
elongate the C-terminus of STIM1 and expose the CAD to activate the CRAC channel 
continuously (140). Moreover, six missense mutations (Orai1- S97C, G98S, V107M, 
L138F, T184M, and P245L) have been found at the TM domains of Orai1 in these 
patients, all causing high resting cytosolic Ca2+ levels (133, 141-143). G98S and V107M 
have been shown to conduct spontaneous Ca2+ influx independent of STIM1, while 
T184M and P245L display excessive Ca2+ influx with STIM1 (144). 
In order to better understand the function of CRAC channels in vivo, several lines 
of mice lacking Orai1 or STIM1/STIM2 genes have been generated in the last decade. 
Most mice lacking Orai1 or STIM1 show perinatal death due to complicated 
pathological conditions including poor skeletal muscle development and respiratory 
failure (79). However, partial survival can be achieved by intercrossing the Orai1/STIM1 
knockout mice (C57Bl/6) with outbred ICR mice, or by using mice with mixed genetic 
backgrounds, or by performing conditional knockout to delete Orai1/STIM1 only in 
specific cell types (108, 145-147). Consistent with human patients, most of these 
surviving mice have significantly diminished CRAC channel function in CD4+ and CD8+ 
T cells, B cells, mast cells, macrophages, and fibroblasts (108, 145-147). As a result, the 
expression of cytokines (e.g., IL-2, IL-4, IL-6, and interferon-γ) by T cells and mast cells 
are remarkably downregulated, while the proliferation of B cells is inhibited as well 
(108, 146). In STIM1 knockout and STIM1/2 double knockout mice, 




conditions are also observed (108, 148). Regarding skeletal muscle composition, STIM1 
knockout mice displayed large muscle loss and mitochondriopathy, causing perinatal 
lethality (149). In addition, the Orai1 or STIM1/2 knockout mice display some other 
phenotypes, including notably smaller size and hair loss, which are partially related to 
the symptoms in human patients (79).  
Taken together, proper activation of the CRAC channels is critical for function of 
the immune system, skeletal muscles, and other tissues (e.g., teeth and sweat glands) in 
humans and mice. While both LOF and GOF, defects of the CRAC channels cause 
significant impairment of cell/tissue development and function, complete loss of CRAC 
channel activity leads to lethal pathological conditions in human patients and knockout 
mouse models. 
 
1.8. CRAC channels in the vascular system 
In the blood vascular system, the expression of Orai and STIM proteins has been 
discovered in both vascular smooth muscle cells (VSMCs) and BECs (150-153). In the 
VSMC, Ca2+ signaling is mediated by many different Ca2+ permeable channels (e.g., 
voltage-gated L-type Ca2+ channels, CRAC channels, receptor-operated channels, 
stretch-activated channels, and transient receptor potential channels), so the role of the 
CRAC channels in cellular function is complicated (154). Although CRAC channel 
blockage by either anti-Orai1 antibody or RNAi against Orai1 inhibits the contractile 
responses in mouse aorta VSMCs in vivo and ex vivo, CRAC channel blockers have little 




suggest that the Ca2+ signaling regulating the contractile profile of the VSMC requires 
CRAC channels when the SR is depleted but is relatively independent of CRAC 
channels in maintaining its tone when the SR Ca2+ store is not significantly altered (158). 
On the other hand, the expression and activity of the CRAC channels are enhanced 
during VSMC proliferation and migration, and suppressing CRAC channels by siRNAs 
targeting of either Orai1 or STIM1 impairs the proliferation and migration of aortic 
VSMCs in vitro, indicating the essential role of the CRAC channels in the VSMC 
remodeling processes (151, 155, 157, 159, 160). A possible explanation is that CRAC 
channel function is required for platelet-derived growth factor (PDGF) signaling, the 
major signaling pathway controlling the recruitment of VSMCs in angiogenesis (157).  
Intriguingly, the CRAC channel is also critical for the VEGF signaling, 
proliferation, and migration of human umbilical vein endothelial cells (HUVECs) in 
vitro (161). Blocking CRAC channels with blockers or protein knockdown results in 
remarkable defects in cell growth and tube formation that mimics angiogenesis in vitro 
(141, 161). Consistently, knockout of Orai1 or STIM1 in mice inhibits the formation and 
remodeling of the carotid artery in vivo, indicating the essential role of the CRAC 
channels in the blood vessel formation and remodeling processes (159, 162, 163). 
Moreover, ICRAC is important for the Ca2+ mobilization upon histamine stimulation, 
downstream NFAT translocation, and IL-8 expression in HUVECs, suggesting that the 
CRAC channel participates in the inflammatory responses in the vasculature (164). 
Compared with the findings in the blood vessels, the knowledge of the CRAC 




magnitude-dependent Ca2+ dynamics in cultured human dermal LECs (HDLECs) and a 
CRAC channel blocker, Synta66, can inhibit this Ca2+ response, indicating a possible 
involvement of the CRAC channels in FSS-elicited Ca2+ dynamics in LECs (165). 
Recently, Orai1 was found to be important for laminar flow-induced LEC proliferation 
and lymphatic growth through a complex formed by Krüppel-like factors (KLF) and 
PROX1 (166, 167). However, the detailed characterization and molecular basis of the 
CRAC channels in the Ca2+ mobilization following FSS or other stimuli in the lymphatic 
system remains to be elucidated. Furthermore, how the CRAC channel participates in the 
regulation of lymphatic function in physiological and pathological conditions is still 
largely unknown. 
 
1.9. Specific aims of this dissertation 
The first aim of this dissertation was to determine the role of the CRAC channels 
in the mechanotransduction of FSS and the downstream signaling pathways in LECs. 
We first examined the involvement of the CRAC channels in the Ca2+ dynamics upon 
FSS application on HDLECs utilizing single-cell calcium imaging, pharmacological 
drugs, and molecular biological tools. We further studied the necessity of CRAC 
channels in NFAT translocation and following transcriptional reprograming after FSS 
stimulation. 
The second aim of this dissertation was to demonstrate the function of the CRAC 
channels in the histamine responses in LECs. We examined the role of the CRAC 




blockers and RNA interference. Additionally, we tested the possible histamine receptor 
and the downstream enzyme that releases the ER Ca2+ store to activate the CRAC 
channels. We also studied the function of the CRAC channels in the hyperpermeability 




2. THE CRAC CHANNELS ARE RESPONSIBLE FOR THE FLUID SHEAR 
STRESS-INDUCED INTRACELLULAR CALCIUM MOBILIZATION IN 
LYMPHATIC ENDOTHELIAL CELLS 
 
2.1. Overview 
 Background: LECs are responsible for regulating the strength and the contraction 
frequency of lymphatic pumping in response to the dynamic changes of lymph flow/FSS 
under physiological and pathophysiological conditions. Previously, we reported that the 
flow-evoked calcium mobilization involves both intracellular Ca2+ store release and 
extracellular calcium entry, in a manner that is sensitive to the magnitude of FSS in 
LECs. However, the precise ion channel molecule(s) involved in this process are 
unknown. CRAC channels are critical for many essential cellular processes and 
functions, including cell activation, proliferation, apoptosis, migration, contraction, and 
secretion. Nevertheless, the role of CRAC channels in mechanotransduction in LECs 
remains elusive.  
 Methods: The [Ca2+]i was measured using a calcium imaging technique in 
cultured HDLECs subjected to constant FSS. An application of channel blockers, RNAi, 
and overexpression of dominant-negative (DN) channel subunits were utilized to unveil 
the channel molecule(s) involved in the mechanotransduction in HDLECs. Additionally, 
mRNA sequencing (RNA-Seq) was employed to show the transcriptional 





 Results: Pharmacological blockade of CRAC channels and DN-Orail1 
overexpression abolished the FSS-induced Ca2+ entry as well as the Ca2+-dependent 
nuclear translocation of NFAT for the regulation of downstream gene expression. 
Consistently, knocking down the endogenous Orai1 or STIM1 by siRNA transfection in 
HDLECs suppressed [Ca2+]i mobilization and its downstream signaling. RNA-seq in 
HDLECs revealed significant transcriptional regulation by FSS, including the 
downregulation of proinflammatory cytokines and chemokines, that was partially 
reversed by CRAC channel blockage.  Moreover, our data demonstrated that 
purinoceptors (P2X/2Y), but not Piezo1/2 or TRPV4, were involved in the FSS-induced 
[Ca2+]i mobilization in our model. 
 Conclusions: Here we show that CRAC channels, formed by Orai1 and STIM1 
proteins, are responsible for mediating both thapsigargin- and FSS-evoked Ca2+ entry in 
HDLECs. Our results indicate that CRAC channels serve as a signal transducer in the 
lymphatic vessels to convert physical stimulations (FSS) into intracellular Ca2+ signals 
and the downstream regulation of gene expression. The FSS-induced Ca2+ signaling has 
been proposed to regulate nitric oxide (NO) production, lymphatic remodeling, and 
lymph transportation; thus, our research is expected to have a potentially strong impact 









The blood and lymphatic endothelium constantly sense the fluid shear stress 
(FSS) for the proper modulation of vessel functions and remodeling (168). The vessel 
tone and permeability are dynamically regulated by FSS in both blood and lymphatic 
vessels, while the pumping activity is also modulated by FSS in collecting lymphatic 
vessels (43, 169). Some molecular mechanisms of these regulations have been 
characterized in BECs. Laminar FSS evokes an acute increase in [Ca2+]i in these ECs, 
promotes endothelial nitric oxide synthase (eNOS) activity through both calmodulin-
dependent and -independent mechanisms to enhance the production of nitric oxide (NO), 
and thereby relaxes vascular smooth muscle cells and reduces vessel tone (170). On the 
other hand, oscillatory FSS not only stimulates an acute increase of NO, but also 
promotes a sustained production of reactive oxygen species (ROS) through nicotinamide 
adenine dinucleotide phosphate hydrogen (NADPH) oxidase and, therefore, potentially 
causes endothelial inflammatory responses (171). In rat lymphatic vessels, 
physiologically-high FSS significantly decreases the vessel tone, pumping frequency, 
and pumping amplitude (43). This modulation is partially caused by eNOS-NO signaling 
but may also involve histamine synthesis and production (172). Additionally, FSS has a 
critical impact on EC alignment, cellular skeleton arrangement, and vascular remodeling 
(173). Disrupted FSS patterns are major causes of inappropriate cellular responses and 
vascular diseases, including atherosclerosis and inflammation, highlighting the 
importance of understanding and regulating the cellular processes involved in the 




The lymphatic vasculature starts as a blind-ended conduit transporting body 
fluid, macromolecules, lymphocytes, and lipids from the interstitial space back to the 
blood circulation (1, 2, 165). The lymphatic system has a vital role of immune 
surveillance by transporting antigens and antigen-presenting cells to the lymph nodes 
and then transporting activated immune cells and secreted cytokines to the blood (25, 
175, 176). The lymph flow has a much smaller velocity and varying oscillations 
compared with blood flow in arteries or veins, but still shows a notable regulatory effect 
on the vessel tone and contractions, and hence controls the rate of lymph transportation 
(1, 177, 178). Due to the large differences between the flows applied to ECs and LECs in 
the blood and lymphatic circulation, LECs are considered to present unique sensitivity 
and responses to the FSS (5, 177). 
Intracellular Ca2+, as a ubiquitous key second messenger, modulates various cell 
processes and functions in vascular ECs (179). Chronic Ca2+ signaling is required for the 
EC proliferation and tube formation in responding to VEGF that is critical for 
angiogenesis and vascular remodeling (161, 180). An acute increase of [Ca2+]i is 
responsible for the NO production via phosphorylated eNOS and cytoskeleton 
reorganization through activated myosin light chain kinase (MLCK), which regulates 
vessel tone and permeability (181-184). FSS is known to trigger a significant increase of 
[Ca2+]i in ECs and LECs; however, the detailed Ca2+ conducting channels, downstream 
signaling pathways, and mechanotransduction mechanisms remain unclear (165, 185). 
The SOCE, mediated by Ca2+ release-activated Ca2+ (CRAC) channels, is a 




environment after the depletion of the ER/SR Ca2+ store (78, 84-87, 89-91, 186). 
Sustained Ca2+ entry through CRAC channels is vital for various cell functions (e.g., T 
cell activation and EC proliferation) but has not been elucidated in the 
mechanotransduction in ECs or LECs (187-189). 
In recent studies, we measured the FSS-mediated [Ca2+]i dynamics in HDLEC 
and showed that the calcium level was dependent on the magnitude of FSS and came 
from both the intracellular Ca2+ stores and the extracellular environment (165). We 
further identified the sensitivity of [Ca2+]i dynamics to the pharmacological blockage of 
CRAC channels using Synta66 (165). Another recent study also discovered that Orai1-
mediated Ca2+ influx is necessary for formation of the KLF2/PROX1 complex and flow-
induced lymphatic sprouting (166, 167). In this study, we investigated the Ca2+ channel 
molecules and Ca2+ signaling involved in the mechanotransduction and downstream 
transcriptional regulation in LECs. Our data indicate that Orai1 and STIM1 mediates the 
[Ca2+]i dynamics upon FSS stimulation in LECs, resulting in NFAT nuclear 
translocation and global regulation in gene transcription. 
 
2.3. Materials and methods 
2.3.1. Cell culture 
HDLECs derived from juvenile human foreskin were obtained from PromoCell 
and cultured in the microvascular endothelial growth medium 2 (MV2), also from 
PromoCell. HDLECs were maintained following the manufacturer’s protocol and 




for all the experiments. For [Ca2+]i imaging or confocal imaging, cells were seeded onto 
glass coverslips pretreated with 2% gelatin. 
2.3.2. Shear stress apparatus 
The shear stress applied to the HDLECs was generated by a mechanical stirrer 
consisting of a precision controller and a rotating whip (Instech Laboratories, Inc.) or an 
orbital shaker (Lab-line Instruments, Inc.). The fluid flow velocity was measured using 
fluorescent microspheres with a spinning disk confocal microscopy technique. 
Fluorescent microspheres (d = 0.5 μm) were obtained from Fisher Scientific and the 
movement traces of the microspheres were measured right above the cytoplasmic 
membrane using a spinning disk confocal microscope (Leica) with an exposure time of 
30 msec. The cells were visualized by loading them with the Celltracker Green CMFDA 
dye (Thermo-Fisher Scientific) 30 min before experiments. The distance of movement 
within 30 msec was measured with the ImageJ software and the velocity was calculated 
using the equation Velocity = Distance / Exposure time. The fluid shear stress was 
calculated using τ = μ
du
dy
 , where τ is the fluid shear stress, µ is the dynamic viscosity of 
the fluid, u is the velocity of the fluid along the boundary, and y is the height above the 
boundary. 
2.3.3. Chemicals and solutions for Ca2+ imaging 
Thapsigargin and BTP2 were purchased from EMD. ATP was obtained from 
Fisher Scientific. Suramin sodium salt was obtained from VWR. Gelatin solution (2 %), 
GdCl3, and other chemicals in the solutions were purchased from Sigma. The salt 




mOsm ± 2%. The pH was 7.35 and was adjusted with the appropriate amount of sodium 
hydroxide. 
2.3.4. Single-cell Ca2+ imaging 
Ca2+ imaging was performed on an IX-81 (Olympus) microscope-based system, 
as described previously (190). HDLECs were incubated with 2 µM Fura-2 AM in the 
culture medium at 37°C for 40 minutes. Transfected cells were identified by the 
presence of fused eGFP; Semrock filters (BrightLine single-band multi-exciter filter set, 
optimized for Fura-2) were used to minimize contamination of Fura-2 fluorescence by 
bleed-through of eGFP fluorescence. Data were analyzed with the Metafluor software 
(Universal Imaging) and the OriginPro 8 software (OriginLab) and are expressed as 
means ± standard error of mean (SEM). 
2.3.5. RNA interference 
For knockdown of Orai1, Orai2, Orai3, STIM1, STIM2, Piezo-1, and Piezo-2, a 
mixture of four siRNAs was purchased from Dharmacon. HDLECs were transfected 
with siRNAs using the Lipofectamine RNAiMAX Transfection Reagent (Life 
Technologies) according to the manufacturer's instructions. 
2.3.6. Molecular cloning and transfection 
The generation of eGFP-tagged wild-type (WT) hOrai1, hOrai1-E106A mutant, 
and recombinant adenoviruses carrying eGFP-NFATc1 was described previously (164). 
HDLECs were transfected (Amaxa Nucleofector Kits, Lonza) with plasmid clones and 




2.3.7. RNA isolation and reverse transcription polymerase chain reaction (RT-
PCR) 
Total RNA was isolated from HDLECs using the RNeasy Mini Kits (Qiagen), 
following the manufacturer’s protocol. The first-strand cDNA was generated using the 
SuperScript IV First-Strand Synthesis System (Thermo-Fisher Scientific) and RT-PCR 
was conducted as described before (164, 191). The quantitative reverse transcription 
polymerase chain reactions (qRT-PCRs) were performed using RT2 SYBR Green ROX 
qPCR Mastermix (Qiagen). 
2.3.8. mRNA sequencing and analysis 
The HDLECs were cultured to form a monolayer and treated with orbital FSS on 
an orbital shaker placed in the incubator for 2 hours. The total RNA was extracted from 
HDLECs using RNeasy Mini Kits (Qiagen) following the manufacturer’s protocol with 
all additional washes and on-column DNase I treatment. RNA concentration and 
integrity were determined using a Nanodrop and Agilent 2100 Bioanalyzer, respectively. 
Samples with the RNA integrity number (RIN) larger than 7.1 were utilized for library 
construction using the NEBNext mRNA Library Prep Reagent Set for Illumina (NEB 
inc.). Purified libraries were sequenced on an Illumina NovaSeq 6000 sequencer at 
paired-end 150 bp coverage depth and 20 million raw reads per sample. The output reads 
were first trimmed out to remove adaptors and then mapped to the human genome 
(GRCh38.p10) using a combined pipeline of TopHat2 (192) and bowtie2 (193). The 
mapped reads were counted and summarized using featureCounts (194). Differential 




Gene ontology and pathway enrichment analysis were performed using DAVID 
Bioinformatics Resources 6.8 (196, 197). 
2.3.9. Western blots 
Whole cell extracts were resolved by SDS-PAGE and transferred to 
nitrocellulose membranes using a transfer apparatus, according to the manufacturer’s 
protocols (Bio-Rad). Samples were then analyzed by standard western blotting. 
Immunoblots were incubated with the primary antibodies as indicated, including rabbit 
anti-STIM1 (1:1000), rabbit anti-STIM2 (1:500, Alomone Labs), mouse anti-GAPDH 
(1:10,000, Fitzgerald clone 6C5), rabbit anti-Orai1 (1:500, Aviva Systems Biology), and 
mouse anti-GFP-HRP (1:1000, Miltenyi Biotec). 
2.3.10. Enzyme-linked immunosorbent assay (ELISA) 
The ELISA targeting interleukin 8 was performed utilizing the Human 
CXCL8/IL-8 Quantikine ELISA Kit (R&D Systems), following the manufacturer’s 
protocol. 
2.3.11. Confocal imaging 
HDLECs were seeded on 35-mm glass bottom dishes (MatTek) coated with 2% 
gelatin. HDLECs were fixed by 4% PFA after shear stress treatments for 1 hour at room 
temperature. Fixed cells were washed with PBS and viewed under a confocal laser-
scanning microscope (FV300; Olympus) equipped with the FluoView software. 
Confocal microscopy was performed at the Integrated Microscopy and Imaging 
Laboratory in the Department of Medical Physiology, Texas A&M University Health 




2.3.12. Statistical analysis 
All data collected were from at least three independent experiments and are 
expressed as mean ± SEM. Statistical significance was evaluated using SAS software 
(University Edition) and assessed by one-way ANOVA and Tukey post-hoc test or 
unpaired t-test. Statistically significant differences were assumed at P-value ≤ 0.05. 
 
2.4. Results 
2.4.1. CRAC channel blockers can inhibit FSS-induced Ca2+ influx 
 Based on the fact that FSS-induced [Ca2+]i mobilization in HDLECs (1) has two 
typical components of CRAC channel-mediated [Ca2+]i mobilization (i.e., release of the 
intracellular Ca2+ store and the extracellular Ca2+ entry) and (2) is sensitive to Synta66, a 
CRAC channel blocker, we tested the hypothesis that CRAC channels are involved in 
mediating this mechanotransduction event. We started with measuring store-operated 
Ca2+ entry in HDLECs in a traditional way via the application of thapsigargin (TG), a 
sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) pump inhibitor, in the absence of 
extracellular Ca2+ (the Ca0 solution, see Table 1), which passively depletes Ca2+ from 
the store in conjunction with evoking SOCE (Figure 1A). A peak (746 ± 38 nM) of the 
[Ca2+]i signal was observed characteristically within two minutes after the addition of a 
physiological saline solution containing 2 mM Ca2+ (Ca2, see Table 1), followed by a 
plateau stage lasting for tens of minutes (600 ± 34 nM at the time point of 5 minutes 
following the Ca2 addition, Figure 1D). As expected, this Ca2+ influx was highly 




Table 1 Saline solution composition (all concentrations in mM) 
Solution Ca2 Ca0   
NaCl 155 153   
KCl 4.5 4.5   
CaCl2 2 0   
MgCl2 1 3   
EGTA 0 1   
HEPES 5 5   






BTP2 (Figure 1B-D), indicating that CRAC channels are likely the main channel 
molecules conducting SOCE in HDLECs. 
For the next step, we set up a system with a mechanical stirrer consisting of a 
precision controller and a rotating whip on top of the cultured cells as our main method 
to apply FSS to HDLECs for [Ca2+]i monitoring. Significant [Ca2+]i mobilization was 
observed as anticipated and the signal increased when the FSS rose (Figure 2A). Under a 
setting with an estimated 4 dyne/cm2 FSS, a constant/stable, saturated [Ca2+]i signal was 
recorded with a peak (747 ± 16 nM) and a gradually decreased plateau (662 ± 18 nM, 
measured 20 minutes after the initiation of the FSS (Figure 2). Removing the 
extracellular Ca2+ from the bath solution dramatically diminished but did not completely 
abolish the [Ca2+]i signal, with a remaining, transient peak (108 ± 7 nM, Figure 2). This 
observation confirms that FSS-induced [Ca2+]i mobilization has two components as 
mentioned above, which was further validated in our complementary experiments using 
Mag-Fluo4, a low affinity Ca2+ binding dye and ER Ca2+ indicator, to detect a significant 
drop in the [Ca2+]ER of HDLECs upon FSS stimulations (Figure 2B). Interestingly, the 
FSS-induced Ca2+ influx can also be effectively inhibited by both Gd3+ and BTP2 
(Figure 3A-D), suggesting a potential major contribution of CRAC channels in 







Figure 1. TG-triggered (store-operated) Ca2+ entry is strongly suppressed by 
CRAC channel blockers in HDLECs. 
A. Representative [Ca2+]i (mean ± SEM) measurements show TG (2 µM)-evoked, store-
operated Ca2+ entries in HDLECs (n = 12 cells). The top bars indicate the type of 
extracellular solutions (Table 1) applied to the cells, and the vertical lines on the x-axis 
indicate the time of solution change. B and C. Representative [Ca2+]i recordings show 
TG-evoked Ca2+ entries with low doses of CRAC channel blockers, Gd3+ (10 µM, n = 11 
cells, B) and BTP2 (10 µM, n = 8 cells, C). D. Statistical analyses of averaged, sustained 
[Ca2+]i values coupled to the TG-dependent Ca2+ influx, obtained at 10 minutes after the 
application of TG, for the three groups of cells (n = 85, 32, and 30 cells, respectively). 






Figure 2. FSS-induced intracellular Ca2+ dynamics in HDLECs. 
A. Representative [Ca2+]i traces show the cytosolic Ca2+ dynamics in HDLECs at the 
static condition in Ca2 solution (grey), subjected to low FSS in Ca2 solution (blue), or 
subjected to high FSS in Ca2 (black) or Ca0 (orange) solutions. B. Representative 
fluorescence intensity traces show the Ca2+ levels in the ER at static condition (grey) or 





2.4.2. FSS-induced Ca2+ entry can be suppressed by a DN Orai1 mutant (Orai1-
E106A) or RNAi against Orai1 or STIM1 
 We next worked to dissect the molecular mechanism underlying this FSS-
triggered [Ca2+]i mobilization in LECs via more specific molecular biology tools. To 
identify the specific channel molecule(s) that mediates the Ca2+ entry following FSS-
evoked store release, we employed Orai1-E106A, a well-established dominant-negative 
Orai1 mutant to suppress the activity of endogenous Orai channels, the best-
characterized store-operated channels so far (87). The point mutation, E106A, is located 
on the channel selectivity filter and upsets channel function by altering/eliminating the 
channels’ permeability to Ca2+. The eGFP alone (the negative control) and the eGFP-
fused Orai1-E106A cDNA constructs were delivered into HDLECs via nucleofection. 
While the cells expressing eGFP responded normally to the TG stimulation (Figure 4A 
and 4C) and the FSS stimuli (Figure 4D and 4F), the cells expressing eGFP-Orai1-
E106A displayed diminished store-operated Ca2+ entries in response to TG (Figure 4B 
and 4C) as well as FSS (Figure 4E and 4F), emphasizing a central role of Orai channels 
in FSS-evoked Ca2+ influx. 
There are three genes (hOrai1, hOrai2, and hOrai3) in the human genome that 
code for the Orai channel pore-forming subunits (Orai1, Orai2, and Orai3, respectively) 
with similar Ca2+/CRAC channel functions at the molecular level; yet it seems that Orai1 
is much more dominant in controlling CRAC channel physiological functions in most 
cellular systems tested so far. To evaluate their potential, functional roles in mediating 






Figure 3. FSS-induced Ca2+ entry is sensitive to CRAC channel blockers in 
HDLECs. 
A. A representative, averaged [Ca2+]i trace shows FSS-evoked Ca2+ entries in HDLECs 
(n = 17 cells). B and C. Representative [Ca2+]i measurements show FSS-evoked Ca2+ 
entries in HDLECs are suppressed by both CRAC channel blockers, Gd3+ (n = 16 cells, 
B) and BTP2 (n = 19 cells, C). D. Statistical analyses of the averaged, peak [Ca2+]i 
values coupled to the FSS-dependent Ca2+ influx for the three groups of cells (n = 201, 
85, and 46 cells, respectively) confirmed significant decrease of FSS-induced Ca2+ 
mobilization by classic CRAC channel blockers in HDLECs. **: p < 0.01 compared 







Figure 4. SOCE and FSS-induced Ca2+ mobilizations are both abolished by Orai1-
E106A, a dominant-negative Orai1 mutant. 
A and B. Representative [Ca2+]i responses show TG-evoked Ca2+ mobilizations in 
HDLECs transfected with eGFP (n = 4 cells, A) or the eGFP-Orai1-E106A mutant (n = 
5 cells, B). D and E. Representative [Ca2+]i measurements show FSS-evoked Ca2+ 
mobilizations in HDLECs transfected with eGFP (n = 8 cells, D) or eGFP-Orai1-E106A 
(n = 4 cells, E). C and F. Statistical analyses of averaged peak [Ca2+]i values coupled to 
stimulations/treatments (TG, n = 37 and 15 cells, C or FSS, n = 30 and 25 cells, F) 






transfected with siRNAs against individual Orai genes separately to disrupt the 
endogenous expression of the corresponding channel subunits. Cells that were not 
treated (non-transfected, NT) were tested in parallel. While Orai2-siRNAs or Orai3-
siRNAs did not significantly alter TG-evoked Ca2+ influx, compared with untreated cells 
(Figure 5A, 5C, 5D, and 5E), Orai1-siRNAs treated cells showed very little SOCE 
overall upon TG stimulation (Figure 5B and 5E), indicating that Orai1 is the main 
CRAC/Orai channel subunit functioning in LECs to conduct SOCE. Consistently, RNAi 
against Orai1, but not Orai2 or Orai3, also prevented HDLECs from responding to the 
FSS stimuli for intracellular Ca2+ mobilization (Figure 6A–6E). The effects of RNAi on 
the expression of Orai genes, especially hOrai1, was confirmed by both RT-PCR (Figure 
5F) and western blot (Figure 6F). 
Orai channels are nowadays known to be activated by physical interactions with 
the STIM molecules located on the ER membrane, which oligomerize upon Ca2+ release 
from the ER and migrate toward the ER-PM junctions. Therefore, we also examined the 
involvement of hSTIM1 and hSTIM2, the two human STIM genes, in mediating both 
SOCE and mechanotransduction of the FSS in HDLECs via RNAi. In cells transfected 
with siRNAs specifically targeting STIM1, TG and FSS failed to stimulate Ca2+ influx 
(Figure 7A, 7B, 7D, 7E, 7G, and 7H). In contrast, gene silencing of STIM2 did not 
considerably reduce Ca2+ influx in response to TG or FSS (Figure 7C, 7F, 7G, and 7H). 
The specificity and efficacy of all the STIM siRNA species on HDLECs were verified 






Figure 5. SOCE is mediated by Orai1, but not Orai2 or Orai3, in HDLECs. 
A-D. Representative [Ca2+]i traces from HDLECs show TG-evoked Ca2+ entries with no 
extra treatment (NT, n = 13 cells, A) or treated with siRNAs targeting Orai1 (n = 16 
cells, B), Orai2 (n = 13 cells, C) or Orai3 (n = 23 cells, D) for three days. E. Statistical 
analyses of averaged, peak [Ca2+]i values coupled to TG-dependent Ca2+ influx show a 
significant decrease of SOCE, compared to cells treated with no treatment, by RNAi 
against Orai1, but not Orai2 or Orai3 (n = 85, 45, 31, and 49 cells, respectively). **: p < 
0.01 compared with the control (NT). F. Representative RT-PCR results confirm 
siRNA-mediated gene silencing of Orai1, Orai2, or Orai3 in HDLECs. The mRNA 
levels of GAPDH from individual samples were examined to verify the application of 






Figure 6. FSS-induced Ca2+ entry is mediated by Orai1, but not Orai2 or Orai3, in 
HDLECs. 
A-D. Representative [Ca2+]i measurements show FSS-evoked Ca2+ entries in HDLECs 
with no treatment (n = 17 cells, A) or treated with siRNAs against Orai1 (n = 25 cells, 
B), Orai2 (n = 34 cells, C) or Orai3 (n = 9 cells, D). E. Statistical analyses of averaged, 
peak [Ca2+]i values coupled to FSS-dependent Ca2+ mobilizations confirm a significant 
decrease, compared to cells with no treatment, by Orai1 RNAi, but not Orai2 or Orai3 
RNAi (n = 201, 109, 90, and 76 cells, respectively). F. Western blot validation of 
siRNA-mediated gene silencing of Orai1 in HDLECs is shown. The protein levels of 
GAPDH from individual samples were examined to verify the application of equal 





These results point out that Orai1 and STIM1 together, the pore-forming and 
activating subunits, respectively, comprise the main type of lymphatic endothelial CRAC 
channel, downstream of the release of the ER Ca2+ store, mediating SOCE as well as [Ca2+]i 
mobilization upon FSS stimuli. 
2.4.3. While Piezo1/2 are not the likely FSS sensor for the observed [Ca2+]i 
mobilization, P2X/2Y receptors may partially contribute to this 
mechanotransduction process 
After the identification of CRAC channels and Orai1/STIM1 proteins as the 
dominant type of Ca2+ channels and their chief underlying molecular components, 
respectively, in LECs to mediate FSS-induced [Ca2+]i mobilization in our settings, our 
next goal is to characterize the upstream signaling pathway and other indispensable 
molecules that directly relay the mechanical force (FSS) to store release/depletion for the 
activation of CRAC channels. For this purpose, we aimed to address the long-sought, 
shear mechanosensor in the lymphatic endothelium. We started with testing a potential 
role of Piezo channels (Piezo1 and Piezo2), a recently recognized two-member family of 
mechanosensitive ion channels. Piezo1 was proposed to act as a shear sensor in 
embryonic BECs for vascular development and structure maintenance, and is able to 
conduct Ca2+ influx under relatively strong FSS stimuli (≥ 5 dym/cm2). It is possible that 
its activation is either upstream or downstream of the activation of CRAC channels 
during all mechanotransduction events. Surprisingly, inhibiting the expression of Piezo1 






Figure 7. SOCE and FSS-induced Ca2+ entry are mediated by STIM1 in HDLECs. 
A-C. Representative [Ca2+]i recordings show TG-evoked Ca2+ entries in HDLECs with 
no treatment (n = 20 cells, A) or treated with siRNAs silencing STIM1 (n = 6 cells, B) or 
STIM2 (n = 14 cells, C). D-F. Representative averaged cytosolic Ca2+ concentrations 
were obtained from FSS-stimulated HDLECs with no treatment (n = 6 cells, D) or 
treated with siRNAs specific to STIM1 (n = 14 cells, E) or STIM2 (n = 18 cells, F). G 
and H. Statistical analyses of averaged, peak [Ca2+]i values following the stimulations 
(TG, n = 85, 65, and 59 cells, G, or FSS, n = 201, 49, and 71 cells, H) show a significant 
decrease of Ca2+ mobilizations upon both types of stimulations by STIM1 RNAi, but not 
STIM2 RNAi. **: p < 0.01 compared with the control (NT). I. Representative Western 
blot results show the specific reduction of the STIM1 and STIM2 proteins in HDLECs 





induced [Ca2+]i mobilization in HDLECs (Figure 8A-8C and 8E). Several anti-Piezo1 
and anti-Piezo2 antibodies were tested, but none of them could clearly detect the 
expression of the corresponding endogenous proteins in HDLECs. On the other hand, at 
the mRNA level, the expression and effective silencing by RNAi of both molecules were 
validated via RT-PCR (Figure 8F). Since Piezo1 and Piezo2 could possibly function 
redundantly at the molecular level or form hetero-trimers as functional channels, we 
tested the effects of silencing both genes at the same time. However, this treatment also 
did not significantly affect the peak amplitude of FSS-induced [Ca2+]i mobilization in 
HDLEC (Figure 8D and 8E). 
After ruling out a possible contribution of Piezo channels in the process of 
mediating [Ca2+]i mobilization in our current settings (relatively low FSS onto cultured 
juvenile LECs), we moved onto the ATP-gated P2X receptors, a family of cation  
channels that has been suggested to be downstream of FSS conducting Ca2+ entry. 
Together with P2Y receptors, another family of GPCRs, these purinergic receptors were 
proposed to be activated by shear-induced release of ATP. In order to validate their 
functional existence in LECs, we stimulated HDLECs with two different concentrations 
of ATP (1 and 10 M) and simultaneously monitored [Ca2+]i mobilization. Within a 10-
minute recording, we constantly observed a sharp but relatively transient peak (300 ± 25 
nM with 1 M ATP and 627 ± 52 nM with 10 M ATP, respectively; Figure 9A-9C) 
evoked within a minute after the application of ATP; consistent with the typical 






Figure 8. Piezo proteins do not contribute to the FSS-induced Ca2+ mobilization. 
A-D. Representative [Ca2+]i recordings illustrate FSS-triggered Ca2+ mobilization in 
HDLECs with no treatment (NT, n = 25 cells, A) or transfected with siRNAs silencing 
Piezo1 (n = 11 cells, B), or Piezo2 (n = 18 cells, C), or both Piezo1 and Piezo2 (n = 13 
cells, D). E. Peak [Ca2+]i values were averaged for comparison (n = 201, 86, 49, and 40 
cells, respectively). F. RT-PCR validation of siRNA-mediated gene silencing of Piezo1 
or Piezo2 in HDLECs is shown. The mRNA levels of GAPDH from individual samples 




evaluate the source/molecular mechanism behind this observed, ATP-dependent [Ca2+]i 
phenomenon in HDLECs, we applied suramin, a universal antagonist to both P2X and 
P2Y receptors, which nearly completely abolished the ATP-induced [Ca2+]i peaks after a 
10-minute pre-incubation with the cells (Figure 9A-9C). Strikingly, suramin also slightly 
reduced FSS-induced [Ca2+]i mobilization (a 16% decrease, Figure 9D-9F), indicating 
that P2X/2Y signaling contributes partially to the mechanotransduction of FSS 
stimulations in our settings. 
Next, we studied a third Ca2+-permeable cation channel, TRPV4, for its potential 
role in our observed FSS-induced [Ca2+]i mobilization. TRPV4 is another channel 
candidate previously proposed to be downstream of FSS for shear mechanosensing. Our 
experimental data showed that with the application/pre-incubation of a TRV4 specific 
antagonist, GSK2193874, the FSS-induced [Ca2+]i mobilization was not influenced in 
our current settings (Figure 9G-9I). 
2.4.4. RNA-Seq revealed a global regulation of transcription and inhibition of 
inflammatory genes triggered by FSS, which is partially dependent on CRAC 
channels 
Following the [Ca2+]i mobilization studies, we investigated the downstream 
regulation of FSS on gene expression. We first tested the possible activation of the 
NFAT, a family of highly Ca2+/calmodulin dependent transcriptional factors. In most 
cell types, NFAT rests in the cytosol until increased [Ca2+]i activates calmodulin and 
thereby dephosphorylates NFAT to induce its nuclear translocation and transcriptional 






Figure 9. FSS-induced Ca2+ entry is partially repressed by a P2X and P2Y receptor 
antagonist but is not influenced by a TRPV4 channel blocker.  
A and B. Representative, averaged [Ca2+]i dynamics were traced from HDLECs 
stimulated by 1 µM (n = 23 and 18 cells, A) or 10 µM (n = 29 and 23 cells, B) ATP, 
with or without the pre-incubation with 100 µM suramin. C. Statistical analyses of 
averaged peak [Ca2+]i values following the ATP treatment confirm the suppressive 
effects from suramin (n = 71, 55, 57, and 74 cells, respectively). D and E. Mobilization 
of cytosolic Ca2+ in response to FSS was also recorded from cells treated with (n = 32 
cells, D) or without (n = 24 cells, E) 100 µM suramin. F. Averaged peak [Ca2+]i values 
from cells stimulated with FSS alone (n = 135 cells) or in the presence of 100 µM 
suramin (n = 245 cells) are shown. G and H. Mobilization of cytosolic Ca2+ in response 
to FSS was also recorded from cells treated with (n = 17 cells, H) or without (n = 18 
cells, G) 100 nM GSK2193874. I. Averaged peak [Ca2+]i values from cells stimulated 
with FSS alone (n = 55 cells) or in the presence of 100 nM GSK2193874 (n = 56 cells) 





with eGFP-tagged NFATc1. The eGFP-NFATc1 molecules were mostly distributed in 
the cytoplasm in static HDLECs (Figure 10A and 10F), while they accumulated in the 
nuclei in HDLECs treated with either TG or FSS for 30 minutes (Figure 10B, 10C, and 
10F). This nuclear translocation was blocked by the knockdown of either Orai1 or 
STIM1 (Figure 10D-10F), supporting our hypothesis that FSS stimulates the nuclear 
translocation of NFAT through CRAC-mediated Ca2+ entry. 
To determine the gene expression profile and transcriptional regulation occurring 
after FSS treatment, HDLECs with normal CRAC channel function or blocked CRAC 
channel function (by Gd3+ or Orai1 knockdown) were treated with FSS via orbital shaker 
for 2 hours in the incubator and the gene expression profile was obtained using RNA-
Seq. The control (static) group and FSS-treated group presented 19252 expressed 
transcripts (detected in at least half of the samples), in which 2364 genes were 
significantly up-regulated after FSS treatment while 2075 were significantly down-
regulated (False Discovery Rate/FDR < 0.05, Figure 11A). We performed gene ontology 
(GO) enrichment analysis on the significantly differentially expressed genes and found 
that they were enriched for the genes involved in cell proliferation, migration, 







Figure 10. CRAC channel-mediated calcium entry is essential for NFAT nuclear 
translocation in HDLECs upon FSS stimulation. 
A-E. Representative confocal images show the subcellular distributions of over-
expressed eGFP-NFAT (green) in HDLECs without treatment (A), pretreated with TG 
(B), FSS (C) or treated with siRNAs against Orai1 (D) or STIM1 (E) before FSS 
stimulations. Scale bars, 20 µm. F. Quantitative results on NFAT nuclear translocation 
from 153 to 434 cells for each set of experiments are shown (n = 341, 359, 434, 153, and 
184 cells, respectively). NT: non-treated, the control group. FSS: the fluid shear stress 







Figure 11. FSS changes the transcriptional expression patterns in HDLECs, which 
is partially reversed by CRAC channel inhibition. 
A. Volcano plot of differentially expressed genes identified in the static HDLECs versus 
in the HDLEC treated with FSS for 2 hours. The y-axis corresponds to the log10 [false 
discovery rate (FDR)], and the x-axis displays the log2 [fold change (FC) value]. The red 
dots represent the significantly differentially expressed transcripts (FDR < 0.05 and FC > 
1); the blue dots represent the transcripts whose expression levels do not reach statistical 
significance (p > 0.05 or FC < 1). B-C. Gene ontology (GO) term enrichment analysis 
for biological processes of (B) up- and (C) down-regulated genes by FSS treatment. For 
each GO term, the fold enrichment is displayed in the x-axis and the false discovery rate 
(FDR) is shown at the end of the bar. D. Heatmap and hierarchical clustering of 
differentially expressed transcripts in HDLECs treated with FSS, or FSS and 10 μM 
Gd3+, or FSS and siRNAs targeting Orai1. The heatmap displays all transcripts that are 
differently expressed in the FSS-treated group compared to the static group; the blue-to-
yellow colors shows the log2(FC) compared to the transcripts in static HDLECs. The red 
lines show where the cluster tree is cut to determine cluster membership and the red 
arrows indicate the clusters where most transcripts are reversed by both CRAC 
inhibitory approaches. E. GO term enrichment analysis for biological processes of the 
genes reversed by both CRAC channel inhibitory methods. F. Quantitative RT-PCR 
showed the relative mRNA expression levels of IL-8 in untreated HDLECs, FSS-treated 
HDLECs, and FSS-treated HDLECs with Gd3+ or Orai1 knockdown. GAPDH was used 
as the reference gene in the quantitative RT-PCR and the results were normalized to the 
IL-8 levels in untreated cells. G. The secreted IL-8 concentrations in the culture medium 
were measured by ELISA for untreated HDLECs, FSS-treated HDLECs, and FSS-
treated HDLECs with Gd3+ or Orai1 knockdown. The IL-8 concentrations were 
normalized to the cell number of each well. The significant differences are marked by 











When further reviewing the top 20 most significantly up-/down-regulated genes 
(Table 2 and Table 3), we noticed the enhanced expression of three members of the 
Krüppel-Like Factor (KLF) family (KLF2, KLF4, and KLF10), together with the 
reduced expression of three endothelial inflammation-related genes (EDN1, IL1R and 
BMP4). After examining all expressed KLF family members (Fragments Per Kilobase of 
transcript per Million mapped reads/FPKM > 0.1), we found a significant increase in 
KLF2, 3, 4, 7, 10, 11, and 13 and a significant decrease in KLF5, 6, and 15 (Figure 
12A). Given that KLF2 and KLF4 are well characterized to be flow sensitive, anti-
inflammatory and atheroprotective in vascular ECs, and while KLF6 is linked to post-
injury responses, we hypothesized an anti-inflammatory effect in HDLEC responding to 
our flow settings. Indeed, we discovered down-regulation of multiple pro-inflammatory 
cytokines and chemokines (e.g., IL-7, CXCL8, IL-16, IL-34, CSF2, CXCL1, and 
CX3CL1); additionally, IL-11 with anti-inflammatory functions was significantly 
enhanced (Figure 12B and C).  
Based on the previously elucidated essential role of CRAC channels in 
transducing FSS to intracellular [Ca2+]i signals, we hypothesized that these 
transcriptional regulations may partially depend on functional CRAC channels. To test 
this hypothesis, we conducted hierarchical clustering on all significantly differentially 
expressed genes in the FSS-treated group compared to the control group (Figure 11D). 
According to the differential expression patterns, genes were divided into 15 branches. 






Figure 12. FSS changes the transcription of KLF proteins, cytokines, and 
chemokines in HDLECs.  
A-C. The expression levels are summarized in the bar graphs showing fragments per 
kilobase of transcript per million mapped reads (FPKM) of KLF family proteins (A), 




Table 2 The top 20 most significantly up-regulated genes after FSS treatment in HDLEC 
revealed by RNA-Seq. 
Ensembl ID Gene Symbol log2FC log2CPM FDR 
ENSG00000127528 KLF2 3.340593 7.5214 0 
ENSG00000154734 ADAMTS1 1.852677 6.047111 0 
ENSG00000157514 TSC22D3 1.982984 5.713949 0 
ENSG00000161940 BCL6B 1.623965 6.863269 0 
ENSG00000168209 DDIT4 2.347908 5.761071 6.80E-291 
ENSG00000171246 NPTX1 2.393685 5.476566 3.07E-277 
ENSG00000111057 KRT18 1.7674 5.572662 2.34E-254 
ENSG00000159388 BTG2 1.403718 6.060101 1.17E-245 
ENSG00000158859 ADAMTS4 1.595409 5.916264 1.49E-240 
ENSG00000065054 SLC9A3R2 1.219064 7.756011 5.45E-221 
ENSG00000178726 THBD 1.080693 7.068044 4.96E-216 
ENSG00000130300 PLVAP 1.157293 7.165574 1.17E-210 
ENSG00000136826 KLF4 3.86256 4.35514 2.33E-210 
ENSG00000124019 FAM124B 1.647365 5.636945 2.20E-205 
ENSG00000138166 DUSP5 1.406011 5.739041 6.14E-193 
ENSG00000136237 RAPGEF5 1.270256 6.09258 3.16E-185 
ENSG00000155090 KLF10 1.266579 6.493032 2.23E-176 
ENSG00000099875 MKNK2 1.078537 7.081555 4.16E-172 






Table 3 The top 20 most significantly down-regulated genes after FSS treatment in 
HDLEC revealed by RNA-Seq. 
Ensembl ID Gene 
Symbol 
log2FC log2CPM FDR 
ENSG00000078401 EDN1 -1.49098 8.5773 0 
ENSG00000091879 ANGPT2 -1.58439 8.050441 0 
ENSG00000198355 PIM3 -1.83446 6.875175 1.30E-243 
ENSG00000168874 ATOH8 -1.6146 6.290829 3.70E-226 
ENSG00000142871 CYR61 -1.12881 9.866753 4.85E-225 
ENSG00000115594 IL1R1 -1.61786 6.079865 7.66E-201 
ENSG00000118515 SGK1 -1.10974 7.558955 2.04E-192 
ENSG00000102760 RGCC -1.60481 5.738586 4.86E-176 
ENSG00000100311 PDGFB -1.09028 8.611032 8.79E-170 
ENSG00000184588 PDE4B -1.0683 6.861541 2.50E-151 
ENSG00000164442 CITED2 -0.89073 6.765355 2.38E-149 
ENSG00000125378 BMP4 -1.18575 6.535266 1.75E-148 
ENSG00000134508 CABLES1 -1.00396 6.123824 2.58E-148 
ENSG00000115738 ID2 -1.8272 4.098779 4.99E-133 
ENSG00000156049 GNA14 -1.21516 5.714715 3.68E-129 
ENSG00000099860 GADD45B -1.21406 6.265636 1.71E-128 
ENSG00000138449 SLC40A1 -0.92876 7.000056 1.89E-125 
ENSG00000253276 CCDC71L -0.78179 7.290359 6.37E-124 





expression by FSS that were reversed by CRAC channel blockage. Specifically, 723 of 
2364 up-regulated genes in the FSS group were significantly reduced in both groups 
with blocked CRAC channels. In contrast, 623 of 2075 transcripts down-regulated by 
FSS were significantly enhanced by CRAC channels inhibition in both groups. These 
1346 genes represent CRAC-dependent transcriptional regulations by FSS. To determine 
the cellular processes linked to these genes, GO enrichment analysis was performed and 
the results showed significant enrichment in genes for vascular smooth muscle cell 
development, angiogenesis, NO synthesis, TGF-β signaling, and NFκB signaling (Figure 
11E). To confirm the role of CRAC channels in the FSS-induced cytokine expression 
change in HDLECs, we performed quantitative RT-PCR and ELISA to study the mRNA 
levels and secreted protein levels of interleukin 8 (IL-8/CXCL8), respectively. FSS 
treatment for two hours was able to reduce the mRNA level of IL-8 by approximately 
65% in HDLECs compared to the untreated cells; however, this effect was completely 
inhibited by CRAC channel blockage with 10 μM Gd3+ or Orai1 knockdown (Figure 
11F). Consistently, treating HDLEC with FSS for 16 hours markedly decreased the IL-8 
concentration in the culture medium by approximately 55% and blocking CRAC 
channels using the same approaches significantly attenuated this alteration (Figure 11G). 
These data suggest that FSS-induced transcriptional reprogramming is partially 
dependent on CRAC channel activity and blocking CRAC channels obstructs some 






2.5. Discussion  
The lymphatic system transports various lymphocytes and antigens, in addition to 
body fluid, macromolecules, and lipids, to the lymph nodes and exports activated 
lymphocytes and immune factors to the blood circulation, thereby maintaining optimal 
immune surveillance and responses (25). Orai1 proteins, CRAC channel forming units, 
were abundantly expressed in multiple primary and secondary lymphoid tissues, 
including thymus, spleens, tonsils, lymph nodes, and lymphocytes, in humans (126, 
146). The patients with defects in CRAC channel molecules suffer from critical immune 
diseases (e.g., Severe Combined Immune Deficiency/SCID and autoimmune diseases) 
caused in part by abnormal lymphocyte functions (90, 126, 129). Consistent with the 
observations in humans, Orai1 or STIM1/2 knockout mice display multiple defects in the 
lymphatic system and the immune system, including splenomegaly, lymphadenopathy, 
and decreased cytokine production by lymphocytes (108, 146). Despite the importance 
of CRAC channels in the lymphatic tissues and immune responses, the channel activities 
and functions are still unclear in the lymphatic vasculature. In the present study, we 
elucidated the expression of CRAC channel components, Orai1 and STIM1, at both 
mRNA and protein levels in HDLECs; we also unveiled a dominant function of CRAC 
channels in mediating the FSS-induced [Ca2+]i dynamics, downstream NFAT nuclear 
translocation, and global transcriptional regulation in HDLECs. These results clearly 
demonstrate the vital role of CRAC channels in the electrophysical transduction of 




Our previous studies specifically showed the FSS-induced [Ca2+]i mobilization in 
LECs from both intracellular and extracellular Ca2+ sources (165), but the identity of the 
channel molecules mediating this Ca2+ signal remained elusive. In this study, we 
revealed that constant FSS stimulation released ER Ca2+ stores and induced a significant 
[Ca2+]i entry via CRAC channels in HDLEC. Application of classic CRAC channel 
blockers and overexpression of DN-Orai1 proteins all robustly reduced the FSS-induced 
Ca2+ mobilization into the cells; moreover, knocking down either endogenous Orai1 or 
STIM1 proteins by siRNAs remarkably diminished the [Ca2+]i peak and abolished the 
plateau, indicating that CRAC channels, formed by Orai1 and STIM1 molecules, are 
predominantly responsible for the Ca2+ entry from the extracellular spaces upon FSS 
stimulation in HDLECs. Orai2/3 and STIM2 were also proposed to mediate Ca2+ entry 
in previous studies but knocking down Orai2/3 or STIM2 did not demonstrate significant 
inhibition of the FSS-induced Ca2+ mobilization in our model, confirming our result that 
Orai1 and STIM1 are the fundamental molecules in this process. 
One of the most intriguing topics in the field of vascular physiology is the 
meticulous mechanism of shear stress sensing and the “sensor” molecules involved. 
Many molecules/complexes have been proposed to sense mechanical forces in different 
flow conditions and various cell types (173, 198-201). Since the commonly observed 
[Ca2+]i dynamics following FSS stimulation in both ECs and LECs suggests the 
involvement of Ca2+ signaling in converting physical forces into intracellular 
electrochemical signals (165, 202), we examined several proposed sensor molecules 




cation channels that are activated by physical stimuli on the PM and convert 
extracellular mechanical signals into cation influx in multiple cell types (203). Piezo1 is 
required for the alignment of BECs responding to blood flow and the development of 
blood vasculature in mice; while Piezo2 is involved in the touch sensation in mice (204-
207). Importantly, loss of Piezo1 function was recently shown to cause congenital 
lymphoedema in human patients carrying mutations in PIEZO1 gene, as well as defects 
in lymphatic valve formation in EC- or LEC-specific PIEZO1 knockout mice (205, 208). 
Together, these in vivo observations suggest an essential role of Piezo proteins in 
vascular development and possibly in LEC mechanotransduction. TRPV4 is another 
channel reported to mediate FSS-induced Ca2+ influx and important in FSS-induced 
blood vasodilation (209, 210). Similarly, the purinoceptors, P2X/2Y, are also extensively 
studied in the mechanotransduction and found to be important in FSS-induced Ca2+ 
influx, BEC alignment, and vasodilation in blood vessels (199, 211-213). Our data in 
this study rejected a principal function for Piezo1/2 proteins or TRPV4 channels in the 
FSS-induced Ca2+ responses using molecular and pharmacological tools. 
Notwithstanding, P2X/P2Y displayed a marginal role in the FSS-induced [Ca2+]i 
mobilization in our experimental setting, implying the potential involvement of ATP in 
FSS processes in LECs. Our results suggest a promising approach to identify shear 
sensing units using Ca2+ responses as convenient readouts. Together with our mRNA-
Seq data showing the transcriptional levels of all highly expressed membrane proteins in 




our study paves the way for further characterization of the direct sensor(s) that convert 
the changes of membrane tension into biochemical signals and release the ER Ca2+ store. 
Besides the shear sensing mechanisms, downstream functional responses in ECs 
are also sophisticated when subjected to distinct flow patterns (168). Specifically, 
disturbed flow (e.g., blood flow in the carotid artery sinus and other branching positions) 
induces inflammatory and atheroprone responses, while high steady flow inhibits these 
responses and is atheroprotective (168, 174). Nevertheless, unlike the relatively steady 
nature of blood flow, lymph flow is extremely dynamic, disturbed at the valve sites and 
branch points and commonly oscillatory in collecting lymphatic vessels at physiological 
conditions, yet show no signs of atherogenesis (1, 5, 177). So the LECs have unique 
responses to various flow patterns. In the present study, our RNA-Seq data showed 
reduced transcription levels of some major pro-inflammatory cytokines and enhanced 
levels of anti-inflammatory cytokines in HDLECs under orbital FSS estimated to be 4 
dyns/cm2. Consistently, we also observed increased expressions of KLF2 and KLF4 that 
were reported to be anti-inflammatory and atheroprotective in atherosclerosis models. 
These findings indicate a potential protective role of orbital FSS in HDLEC, suggesting 
disparate flow responses in LECs compared with BECs.  
In conclusion, we present comprehensive evidence in this study to characterize 
FSS-induced [Ca2+]i signaling and to understand the specific channels and fundamental 
molecules mediating FSS-induced [Ca2+]i dynamics and downstream transcriptome 




of mechanotransduction in LECs and the vascular regulation brought about by flow in 





Table 4 The top 100 most abundantly expressed predicted membrane protein genes in 
HDLEC. 
Ensembl ID Gene Symbol FPKM 
ENSG00000198804 GK 4262.565 
ENSG00000198712 GLMP 3827.362 
ENSG00000198899 L1CAM 3152.669 
ENSG00000198886 MT-ND1 2263.712 
ENSG00000198938 MFAP3L 2088.205 
ENSG00000212907 KIR3DL2 1688.662 
ENSG00000198695 MT-CO2 1540.381 
ENSG00000198727 LRRTM3 1285.865 
ENSG00000198888 SHISA4 1283.146 
ENSG00000198786 TMEM184B 1194.872 
ENSG00000198840 SELENOT 922.6772 
ENSG00000198763 APCDD1L 851.108 
ENSG00000126709 IFI6 794.7977 
ENSG00000106991 ENG 617.5708 
ENSG00000228253 C19orf24 462.943 
ENSG00000142089 IFITM3 426.2275 
ENSG00000084234 APLP2 418.6642 
ENSG00000105974 CAV1 393.9038 
ENSG00000142192 APP 366.9639 
ENSG00000088832 FKBP1A 311.6461 
ENSG00000261371 TMEM249 269.1223 
ENSG00000150938 CRIM1 268.9733 
ENSG00000169100 SLC25A6 264.0027 
ENSG00000161638 ITGA5 263.3546 
ENSG00000179776 CDH5 259.2923 
ENSG00000150093 ITGB1 253.7635 
ENSG00000163513 TGFBR2 236.0307 
ENSG00000134294 SLC38A2 221.8109 
ENSG00000085063 CD59 219.0095 
ENSG00000128567 PODXL 210.1234 
ENSG00000204592 DISP3 209.8835 
ENSG00000234745 SHISA8 195.8041 
ENSG00000129562 DAD1 192.1531 
ENSG00000152661 GJA1 186.4857 
ENSG00000152558 TMEM123 186.2306 
ENSG00000135404 CD63 180.3649 




Table 4 Continued 
Ensembl ID Gene Symbol FPKM 
ENSG00000183255 PTTG1IP 165.8474 
ENSG00000002586 CD99 165.6159 
ENSG00000066056 TIE1 162.0884 
ENSG00000010278 CD9 159.4076 
ENSG00000005022 SLC25A5 158.7829 
ENSG00000176435 CLEC14A 156.0934 
ENSG00000117298 ECE1 153.0533 
ENSG00000004399 PLXND1 152.153 
ENSG00000197747 LHFPL5 148.921 
ENSG00000134352 IL6ST 141.9589 
ENSG00000168899 VAMP5 138.8527 
ENSG00000148175 STOM 136.659 
ENSG00000125810 CD93 132.4288 
ENSG00000127022 CANX 132.2754 
ENSG00000135318 NT5E 131.3201 
ENSG00000100300 TSPO 130.1026 
ENSG00000169908 TM4SF1 120.6594 
ENSG00000170989 S1PR1 120.4933 
ENSG00000228474 LINC01125 120.1467 
ENSG00000204525 MUC21 119.6251 
ENSG00000187513 ATP13A5 118.6901 
ENSG00000118705 RPN2 116.8466 
ENSG00000185201 MC2R 115.5946 
ENSG00000172270 BSG 113.7177 
ENSG00000149925 ALDOA 112.7447 
ENSG00000140564 FURIN 112.6937 
ENSG00000148248 SURF4 108.9876 
ENSG00000058262 SEC61A1 106.1474 
ENSG00000162618 ADGRL4 105.6132 
ENSG00000069849 ATP1B3 105.0178 
ENSG00000157227 MMP14 104.7785 
ENSG00000115310 RTN4 104.5998 
ENSG00000196411 NPIPB15 99.85414 
ENSG00000099282 TSPAN15 98.77917 
ENSG00000198856 LTN1 98.42202 
ENSG00000139644 TMBIM6 97.77429 
ENSG00000136156 ITM2B 97.44957 




Table 4 Continued 
Ensembl ID Gene Symbol FPKM 
ENSG00000185896 FFAR3 95.78088 
ENSG00000181104 F2R 95.15766 
ENSG00000177697 CD151 95.145 
ENSG00000184840 DRD1 92.73211 
ENSG00000143870 PDIA6 91.26543 
ENSG00000110108 TMEM109 91.01703 
ENSG00000154133 ROBO4 90.34233 
ENSG00000076706 MCAM 89.77205 
ENSG00000073008 PVR 89.46667 
ENSG00000162493 PDPN 88.76727 
ENSG00000113732 ATP6V0E1 87.60019 
ENSG00000137409 MTCH1 87.40874 
ENSG00000138448 ITGAV 86.20617 
ENSG00000163399 ATP1A1 85.67757 
ENSG00000114698 PLSCR4 85.50376 
ENSG00000165678 GHITM 85.40497 
ENSG00000111897 SERINC1 83.77665 
ENSG00000136026 CKAP4 83.68886 
ENSG00000120279 MYCT1 83.44524 
ENSG00000101384 JAG1 83.19346 
ENSG00000010327 STAB1 82.79328 
ENSG00000170540 ARL6IP1 82.79269 
ENSG00000198053 43164 81.88087 
ENSG00000112697 TMEM30A 81.59537 




3. THE CRAC CHANNELS ARE RESPONSIBLE FOR HISTAMINE-INDUCED 
CALCIUM ENTRY, HYPERPERMEABILITY, AND INTERLEUKIN SYNTHESIS 
IN LYMPHATIC ENDOTHELIAL CELLS 
 
3.1. Overview 
The lymphatic functions needed to maintain lymph transport and immune 
surveillance can be impaired by infection and inflammation, thereby causing debilitating 
disorders such as lymphedema and inflammatory bowel disease. Histamine is a key 
inflammatory mediator known to trigger vasodilation and vessel hyperpermeability upon 
binding to its receptors and evoking [Ca2+]i dynamics for the downstream signal 
transduction. However, the exact molecular mechanisms behind the [Ca2+]i dynamics 
and the downstream cellular effects have not been elucidated in the lymphatic system. 
Here, we show that CRAC channels, formed by Orai1 and STIM1 proteins, are required 
for the histamine-elicited Ca2+ signaling in LECs. Blockers or antagonists against CRAC 
channels, phospholipase C, and H1R receptors all significantly diminished the histamine-
evoked [Ca2+]i dynamics in LECs. Knockdown of endogenous Orai1 or STIM1 by 
siRNAs also abolished the Ca2+ entry upon histamine stimulation in LECs. Furthermore, 
the histamine-triggered endothelial hyperpermeability and VE-cadherin disruption were 
remarkably attenuated by CRAC channel blockers. Additionally, the upregulated 
expression of inflammatory cytokines, interleukin-6 and -8, after histamine stimulation 
was abolished by silencing Orai1 or STIM1 with RNAi in LECs. Taken together, our 








The lymphatic system provides essential pathways to transport the accumulated 
fluid, proteins, and cells from the interstitial spaces back to the circulatory system, 
thereby maintaining the body fluid homeostasis and immune surveillance (1, 2). 
Compromised lymphatic functions or integrity leads to many severe diseases, including 
lymphedema and inflammation (25). In the past two decades, several studies have 
discovered the critical roles of lymphatic vessels in immune responses and inflammatory 
diseases (e.g., inflammatory bowel disease / IBD and renal inflammations) (22, 37, 175, 
214, 215). LECs line the lumen of lymphatic vessels and are exposed directly to the 
lymph (216-218). LECs remodel their cytoskeleton structures and intercellular junctions 
upon inflammatory stimuli in pathological conditions; they also synthesize cytokines to 
attract leukocytes and mediate leukocyte entry into the lymphatic system to aid in 
immune responses (9, 219, 220). However, the cellular and molecular mechanisms 
underlying the lymphatic responses to inflammatory stimuli are still at early stages of 
understanding. 
Histamine is an important inflammatory mediator released predominantly by 
mast cells and basophils, causing vasodilation, vascular hyperpermeability, smooth 
muscle contraction, arrhythmias and altering lymphatic vessel contractile and pumping 




[Ca2+]i elevation, F-actin remodeling, intercellular junction reassembly, and cytokine 
production in BECs (62, 66, 71-73). Histamine has been shown to activate the PLC 
family through its receptors and generates IP3 and diacylglycerol as second messengers 
to release the ER Ca2+ stores and trigger downstream Ca2+ signaling in BECs (62, 164, 
221).  
The CRAC channel, formed by Orai and STIM proteins, is a key route for 
sustained Ca2+ influx following intracellular Ca2+ store release in various cell types (78, 
84-92, 222). Proper CRAC channel function is essential for the Ca2+ signaling to support 
the activation of T lymphocytes, development of B lymphocytes, and release of 
cytokines from mast cells (186, 187). Previously, we showed that CRAC channels 
mediate Ca2+ entry upon histamine stimulation and are necessary for the NFAT 
translocation and IL-8 production in HUVECs (164). However, the role of CRAC 
channels in the lymphatic responses to histamine, especially the permeability alteration 
and inflammatory responses, remains elusive. 
In this study, we show that histamine-evoked [Ca2+]i increase includes a Ca2+ 
store release through H1R and a sustained Ca2+ influx via CRAC channels in HDLECs. 
This CRAC channel-mediated Ca2+ signaling is required for both increased permeability 








3.3. Materials and methods 
3.3.1. Chemicals 
Physiological saline solutions (Table 1) were prepared using chemicals of 
reagent grade purchased from Sigma-Aldrich. The measured osmolality was 319 mOsm 
± 2% and the pH was adjusted with sodium hydroxide to 7.35. Histamine, gelatin 
solution (2%), diphenhydramine hydrochloride, fexofenadine hydrochloride, and GdCl3 
were also purchased from Sigma-Aldrich. Fura-2 AM, thapsigargin, BTP2, SKF-96365, 
and U-73122 were purchased from Thermo-Fisher Scientific.  
3.3.2. Human dermal lymphatic endothelial cell culture 
HDLECs derived from juvenile human foreskin and microvascular endothelial 
growth medium 2 (MV2) were purchased from PromoCell. HDLECs were maintained 
following the manufacturer’s protocol and passaged with trypsin-EDTA (0.05%) at 
confluence. Cells with passages less than ten were used for all experiments. For [Ca2+]i 
imaging or confocal imaging, cells were seeded onto glass coverslips pretreated with 2% 
gelatin. 
3.3.3. Single-cell [Ca2+]i imaging 
Single-cell [Ca2+]i imaging was conducted using an IX-81 (Olympus) 
microscope-based system, as described previously (223). HDLECs were loaded with 2 
µM Fura-2 AM in the culture medium in the incubator (37 °C and 5% CO2) for 40 
minutes. Loaded cells were briefly washed using Ca2 solution after loading and then 




density and ratio data were analyzed with the Metafluor software (Universal Imaging) 
and the OriginPro 8 software (OriginLab) and expressed as mean ± SEM. 
3.3.4. RNA interference 
For knockdown of Orai1 and STIM1, a mixture of four siRNAs targeting each 
gene was purchased from Dharmacon. HDLECs were cultured to 75% confluency and 
transfected with siRNAs using the Lipofectamine RNAiMAX Transfection Reagent 
(Life technologies) according to the manufacturer's instructions. Cells were used in 
experiments within 60-72 hours post transfection. 
3.3.5. RNA isolation and quantitative RT-PCR  
Total RNA was isolated from HDLECs using the RNeasy Mini Kit (Qiagen) 
following the manufacturer’s protocol. The first-strand cDNA generation was achieved 
with the SuperScript IV First-Strand Synthesis System (Thermo-Fisher Scientific). The 
qRT-PCRs were performed using RT2 SYBR Green ROX qPCR Mastermix (Qiagen). 
GAPDH was used as the reference gene and the primers used in this study are 
summarized in Table 5. 
3.3.6. Western blots 
Whole cell lysates were separated by SDS-PAGE and transferred to 
nitrocellulose membranes using a transfer apparatus according to the manufacturer’s 
protocols (Bio-Rad). Samples were then analyzed by standard western blotting. 
Immunoblots were probed with the primary antibodies including rabbit anti-STIM1 
(1:2500) (85), rabbit anti-Orai1 (1:500, Aviva Systems Biology) and mouse anti-




3.3.7. Immunofluorescence and confocal imaging 
 HDLECs were cultured on glass coverslips pretreated with 2% gelatin to form 
monolayers and treated with 20 μM histamine, 20 μM histamine with 10 μM BTP2, or 
20 μM histamine with 10 μM Gd3+ for 30 minutes in the incubator (37 °C and 5% CO2). 
Cells with or without treatment were then fixed in 4% paraformaldehyde in PBS. VE-
cadherin was recognized with primary anti-VE-cadherin antibody (1:100, Santa Cruz) 
and Alexa Fluor® 594-conjugated secondary antibody (1:200, Thermo-Fisher 
Scientific). Cells were mounted using ProLong™ Gold Antifade Mountant with DAPI 
(Thermo-Fisher Scientific) and finally visualized utilizing a confocal laser-scanning 
microscope (FV300; Olympus) equipped with the FluoView software. Confocal 
microscopy was performed at the Integrated Microscopy and Imaging Laboratory in the 
Department of Medical Physiology, Texas A&M University Health Science Center, 
Temple, Texas. 
3.3.8. Permeability assays 
HDLEC (4 x 104 cells/well) were seeded in 6.5 mm Transwell® filter inserts with 
0.4 μM pores (polyester membrane, Corning-Costar) and cultured to confluence for 48 
hours. For the Transwell® assay, fluorescein isothiocyanate (FITC)-dextran (40 kDa, 
1 mg/ml; Sigma-Aldrich) was added to the upper compartment of the Transwell® inserts 




Table 5 Primers used in qRT-PCR analysis (sequence 5’ → 3’) 
Gene Forward Reverse 
IL-6 GGTACATCCTCGACGGCATCT GTGCCTCTTTGCTGCTTTCAC 
IL-8 AGCACTCCATAAGGCACAAA ACACACAGTGAGATGGTTCC 
SCF CCAGAACCCAGGCTCTTTAC GATTTTTGGCCTTCCCTTTCTC 





incubator (37 °C and 5% CO2). Medium samples (300 μl) were taken from each lower 
compartment and added to three microplate wells (100 μl / well), and fluorescence 
(485 nm / 510 nm) of the samples was measured with a fluorescence plate reader (Bio-
Rad). The mean fluorescence recorded from the sample obtained from untreated cells 
was set as 1. Fluorescence from other groups was expressed as a relative value compared 
to the control level. For the transendothelial electrical resistance (TEER) assay, the 
Transwell® insert with a confluent HDLEC monolayer was installed in an EndOhm Cell 
Culture Cup Chamber (6 mm, World Precision Instruments) with 1 ml of fresh medium. 
The apparatus was placed on a heating pad at 37 °C and TEER was measured by an 
Epithelial Volt/Ohm Meter (EVOM2) together with an STX2 electrode. An empty insert 
with culture medium but no cells was used as the blank for each day’s experiment. For 
each insert with an HDLEC monolayer, a TEER baseline was measured with 180 μl 
medium, and then TEER was further measured after 20 μM histamine, 10 μM BTP2, or 
10 μM Gd3+ was added to the medium. The blank TEER was subtracted from all TEER 
readings and the TEER baseline was set as 1 for each experiment.    
3.3.9. Statistical analysis 
All data were collected from at least three independent experiments and 
presented as mean ± SEM. Statistical significance was evaluated using SAS software 
(University Edition) and assessed by one-way ANOVA and Tukey post-hoc test (among 
multiple groups) or Student's t-test (between two groups). Statistically significant 






3.4.1. Histamine evokes sustained [Ca2+]i dynamics in HDLECs in a dose-dependent 
manner  
To study the [Ca2+]i dynamics in living HDLECs,  we loaded cells with 2 µM 
Fura-2-AM in culture medium for 40 minutes in the incubator and imaged cells in a 
saline solution containing 2 mM Ca2+ (Ca2, see Table 1) at room temperature. Different 
concentrations (10, 20, 50, and 100 µM) of histamine were applied to the cells 
respectively and elicited a dose-dependent increase of [Ca2+]i that peaked within 60 
seconds (Figure 13A - D). When 10 µM histamine was applied, [Ca2+]i approached the 
peak (246 ± 15 nM) within 60 seconds and displayed a slowly descending plateau with a 
sustained [Ca2+]i level of 101 ± 9 nM at 3 minutes after histamine application (Figure 
13A, E, and F). The [Ca2+]i levels returned to the resting state in approximately 6 
minutes post histamine stimulation at 10 µM after a gradually descending plateau 
(Figure 13A). With 20 µM histamine, the [Ca2+]i reached a peak of 338 ± 14 nM and 
maintained a higher plateau with a sustained [Ca2+]i level of 180 ± 8 nM (Figure 13B, E, 
and F). The maximal [Ca2+]i response was achieved at 50 µM histamine with a sharp 
peak of 415 ± 22 nM in 15 seconds and a sustained [Ca2+]i level of 250 ± 10 nM at 3 
minutes after histamine stimulation (Figure 13C, E, and F). Responses to 100 µM 
histamine did not show significant further enhancement of either peak (409 ± 18 nM) or 
sustained (285 ± 13 nM) [Ca2+]i levels in HDLEC (Figure 13D, E, and F). With 50 or 
100 µM histamine, the [Ca2+]i levels were maintained higher than the resting level in our 







Figure 13. Histamine triggers Ca2+ dynamics in a concentration-dependent manner 
in HDLECs.  
A – D. Representative [Ca2+]i recordings show cytosolic Ca2+ concentrations upon 
histamine stimulations at 10 µM (A, n = 15 cells), 20 µM (B, n = 18 cells), 50 µM (C, n 
= 17 cells), and 100 µM (D, n = 26 cells). The top bars indicate the type of extracellular 
solutions (Table 1) applied to the cells and the vertical lines on the x-axis indicate the 
time of solution change. E and F. Statistical analysis of averaged, peak (E) and 
sustained (F) [Ca2+]i levels coupled to histamine stimulations obtained at 3 minutes after 
the application of histamine, for the four different concentrations. Statistically significant 





3.4.2. The histamine-dependent [Ca2+]i dynamics, containing both intracellular Ca2+ 
store release and extracellular Ca2+ entry, are mediated by H1R and PLC in 
HDLECs  
To identify the Ca2+ sources of histamine-triggered [Ca2+]i dynamics in HDLECs, 
we changed the culture medium to a Ca2+-free solution (Ca0, see Table 1) right after 
Fura-2-AM loading to avoid extracellular Ca2+ entry and recorded the [Ca2+]i responses 
after histamine stimulation. Under this condition, the initial increase of [Ca2+]i was still 
observed upon histamine addition without notable delays (Figure 14A and B). However, 
the peak [Ca2+]i levels were lower than the control experiments in Ca2 solution and the 
sustained [Ca2+]i plateau was eliminated in Ca0 solutions (Figure 14A, B, F, and G). 
These results indicate that histamine elicits the initial Ca2+ dynamics by releasing the 
intracellular Ca2+ store but the peak [Ca2+]i and following plateau require Ca2+ import 
from extracellular environments.  
Histamine binds to four subtypes of GPCRs in human cells (H1R – H4R) and H1R 
was shown to mediate Ca2+ signaling in blood endothelium (62, 73). We utilized two 
classical H1R antagonists, diphenhydramine (224) and fexofenadine (225), to evaluate 
the role of H1R in histamine-evoked [Ca2+]i dynamics in LECs. 30 µM diphenhydramine 
or 30 µM fexofenadine in the external Ca2 solution is sufficient to abolish [Ca2+]i 
responses, including both the initial response that existed in Ca0 solution and the 
following plateau, indicating that the blockage of H1R eliminated both intracellular Ca2+ 







Figure 14. Antagonists targeting H1R and PLC completely abolish the Ca2+ 
dynamics induced by histamine in HDLECs.  
A – E. Representative [Ca2+]i traces corresponding to 20 µM histamine in control Ca2 
saline (A, n = 26 cells), Ca2+-free (Ca0) saline (B, n = 17 cells), and Ca2 saline 
containing 30 µM diphenhydramine (C, n = 18 cells), 30 µM fexofenadine (D, n = 21 
cells), or 2 µM U-73122 (E, n = 20 cells). F and G. Averaged peak (F) and sustained 
(G) [Ca2+]i values are summarized and significant differences are denoted by different 






PLC is a major enzyme that connects GPCRs to ER Ca2+ store release by 
catalyzing the hydrolysis of PIP2 to IP3. The produced IP3 then binds to the IP3 receptors 
on the ER membrane to release the ER Ca2+ store (226). To determine whether PLC is 
responsible for the histamine-dependent [Ca2+]i responses in HDLECs, we applied a 
PLC inhibitor, U-73122 (227-231), before the histamine treatment. As expected, the 
histamine-triggered Ca2+ store release and Ca2+ entry were both diminished by 2 µM U-
73122 (Figure 14E). Notably, the peak and sustained [Ca2+]i levels treated with U-73122 
and histamine are comparable to that with H1R antagonists and histamine in HDLECs 
(Figure 14F and G), suggesting that PLC signaling is the dominant pathway linking H1R 
to the ER Ca2+ store release upon histamine stimulation. 
Taken together, our results suggest that histamine-triggered [Ca2+]i dynamics in 
HDLECs is composed of a fast release of the intracellular ER Ca2+ store and a sustained 
Ca2+ influx from the external environment.  Further, these two components of Ca2+ 
mobilization are most likely mediated by H1R binding and downstream PLC activation. 
3.4.3. The histamine-triggered [Ca2+]i mobilization in HDLECs is inhibited by 
multiple CRAC channel blockers 
CRAC channels have been shown to mediate SOCE after ER-store release in 
various cell types including endothelial cells (152, 232), therefore, we applied three 
different CRAC channel blockers, BTP2 (233), Gd3+ (86), and SKF-96365 (234), to 
determine whether CRAC channels mediate the sustained Ca2+ influx upon histamine 
stimulation. First, we validated the effect of three CRAC channel blockers, BTP2 (10 




by 2 µM TG. In the control experiments, TG inhibited the SERCA (235) and passively 
depleted the ER Ca2+ store in Ca0 solution; when Ca2+ was added back, a significant 
increase of [Ca2+]i followed by a gradually descending plateau was observed as the 
SOCE refilled the ER Ca2+ store in HDLECs via CRAC channels (Figure 15A). As 
expected, the three CRAC channel blockers, independently applied to the external 
solution, effectively inhibited the Ca2+ influx through CRAC channels and thereby 
significantly diminished the sustained plateau [Ca2+]i measured at 5 minutes after the 
application of blockers (Figure 15B – E). Interestingly, all three CRAC channel blockers 
were able to abolish the histamine-triggered Ca2+ influx into HDLECs (i.e., the sustained 
[Ca2+]i plateau) but not the initial Ca2+ responses (Figure 16A – D).  The histamine-
evoked [Ca2+]i dynamics in the cells treated with CRAC channel blockers are 
comparable to that in the Ca2+-free solution (Figure 16E and F), suggesting that the 
CRAC channels are likely conducting the Ca2+ mobilization from the external solutions 
but have little impact on the intracellular Ca2+ store release upon histamine stimulation 
in HDLECs. 
3.4.4. Genetic knockdown of Orai1 or STIM1 diminishes the histamine-dependent 
Ca2+ entry in HDLECs 
The CRAC channels in BECs are predominantly formed by Orai1 proteins on the 
PM and STIM1 proteins on the ER membrane (236). To eliminate the possible off-target 
effect of CRAC channel blockers and to study the molecular basis of histamine-triggered 
[Ca2+]i mobilization in HDLECs, we utilized the RNAi technique to genetically 






Figure 15. TG-induced SOCE is inhibited by CRAC channel blockers in HDLECs.  
A – D. Representative [Ca2+]i measurements of SOCE evoked by 2 µM TG in HDLECs. 
Cells were bathed in Ca2 solution (A, n = 24 cells), or Ca2 solution containing 10 µM 
BTP2 (B, n = 23 cells), 10 µM Gd3+ (C, n = 18 cells), or 20 µM SKF-96365 (D, n = 22 
cells). E. Statistical analysis of TG-evoked [Ca2+]i levels at 5 minutes after the 
application of CRAC channel blockers in HDLECs. Significant differences are denoted 







Figure 16. Histamine-induced Ca2+ entry is inhibited by CRAC channel blockers in 
HDLECs.  
A – D. Representative [Ca2+]i traces upon 20 µM histamine addition in Ca2 solution (A, 
n = 17 cells), or Ca2 solution with CRAC channel blockers, BTP2, Gd3+, and SKF-
96365 (B – D, n = 14, 24, and 21 cells, respectively). E and F. Statistical analysis of 
averaged peak (E) and sustained (F) [Ca2+]i levels at 3 minutes after histamine treatment 





targeting Orai1 or STIM1 to disrupt the endogenous expression of these two proteins, 
while non-targeting siRNAs were used as a negative control. We found that the non-
targeting siRNAs-treated cells showed little effect on the TG-evoked and histamine-
triggered Ca2+ dynamics in HDLECs compared to the untreated cells (Figure 17A and 
D). However, cells treated with siRNAs targeting either Orai1 or STIM1 lost the 
majority of their TG-evoked Ca2+ entry, indicating the necessary role of both Orai1 and 
STIM1 in maintaining functional CRAC channels (Figure 17B, C and G). Meanwhile, 
the cells with Orai1 or STIM1 knockdown also showed diminished Ca2+ responses upon 
histamine stimulations (Figure 17E, F and H), again indicating the essential role of 
CRAC channels, formed by Orai1 and STIM1, in mediating the histamine-triggered Ca2+ 
mobilization in HDLECs. The knockdown efficiency of siRNAs targeting Orai1 or 
STIM1 was confirmed by western blot (Figure 17I). 
3.4.5. CRAC channel blockers attenuate histamine-induced VE-cadherin disruption 
and hyperpermeability in HDLECs 
Given that histamine can induce blood vessel leakage by altering the endothelial 
cytoskeleton structures and disassembling cell-cell junctions in inflammatory responses 
(59, 61, 65, 66, 237), we sought to test whether histamine changed the lymphatic 
endothelial permeability and adherens junctions between LECs. The lymphatic 
endothelial permeability was measured by two different approaches, the traditional 
Transwell® assay with FITC - conjugated dextran (238, 239) and the TEER assay (240, 
241). Both methods showed significant increase in lymphatic endothelial permeability 






Figure 17. Histamine-induced Ca2+ dynamics require endogenous Orai1 and 
STIM1 in HDLECs.  
A – C. Representative [Ca2+]i measurements of cytosolic Ca2+ levels responding to TG-
mediated stimulation in untreated HDLECs (A) or HDLECs treated with siRNAs 
targeting Orai1 (B) or STIM1 (C). D – F. Representative [Ca2+]i traces upon 20 µM 
histamine stimulation in untreated HDLECs (D) or HDLECs transfected with siRNAs 
against Orai1(E) or STIM1 (F). G and H. Averaged peak [Ca2+]i values corresponding 
to TG (G) or histamine (H) stimulation in the untreated control group, Orai1 knockdown 
group, and STIM1 knockdown group. **: P < 0.01 compared to the control group. I. 
Western blot of Orai1 and STIM1 proteins after the transfection of siRNAs. MW: 
molecular weight; NT: non-targeting siRNAs; siOrai1: siRNAs targeting Orai1; 




by 40% in histamine-treated wells compared to the untreated control wells (Figure 18 A 
and B). Since we previously discovered that CRAC channel blockers could inhibit 
histamine-triggered [Ca2+]i mobilization in HDLECs, we applied two blockers, BTP2 
and Gd3+, to study the functional role of CRAC channels in histamine-induced 
hyperpermeability in LECs. Intriguingly, the application of BTP2 or Gd3+ significantly 
diminished the histamine-induced leakage in the Transwell® assay and attenuated the 
drop in TEER (Figure 18 A and B), indicating a critical involvement of CRAC channel-
mediated Ca2+ signaling in histamine-induced lymphatic endothelial leakage. 
Because adherens junctions are critical for paracellular transportation and 
endothelial permeability (63), we examined the network structure of VE-cadherin, an 
EC-specific and Ca2+-dependent adherens junction protein, by immunofluorescence. 
Consistent with our permeability data, the untreated confluent HDLEC monolayer 
displayed a strong, continuous, and intact network structure of VE-cadherins located at 
all intercellular contacts (Figure 18 C - E); however, 20 µM histamine treatment for 30 
minutes significantly disrupted this structure and resulted in a weaker and intermittent 
VE-cadherin network with apparent gaps in the intercellular junctional areas (Figure 18 
F - H). Again, the CRAC channel blockers, BTP2 or Gd3+, independently inhibited 
histamine-induced VE-cadherin gaps and protected most intercellular spaces (Figure 18 I 
- N). Although a few gaps were still spotted in the HDLEC monolayers treated with 
histamine and BTP2 or Gd3+, the major VE-cadherin network remained intact, and this 
protection of intercellular junctions could partially explain the effect of CRAC channel 




3.4.6. Orai1 or STIM1 knockdown prevent the enhanced expression of IL-6 and IL-
8, but not SCF, mediated by histamine stimulation in HDLECs 
Histamine, as an essential inflammatory mediator, is known to promote the 
expression of cytokines to attract immune cells in allergic inflammation (71, 72). 
Previously, we reported that histamine enhanced the expression and secretion of IL-8 in 
a CRAC-dependent manner in HUVECs (164). Here, we report that histamine was able 
to remarkably upregulate the mRNA levels of three critical cytokines expressed by 
LECs: IL-6, IL-8, and SCF. Treating HDLECs with 20 µM histamine for 2 hours caused 
3.8-, 3.1-, and 7.9- fold increases of the mRNA levels for IL-6, IL-8, and SCF, 
respectively (Figure 19 A - C). Further treatment for 4 or 6 hours kept the mRNA levels 
significantly higher than those in untreated cells (Figure 19 A - C). Next, we knocked 
down the key components of CRAC channels, Orai1 and STIM1, by transfecting 
siRNAs targeting each gene in HDLECs. Surprisingly, while compromised CRAC 
channels averted the effect of histamine in elevating the expression of IL-6 and IL-8 
(Figure 19 D and E), it led to little impact on the histamine-promoted expression of SCF 
in HDLECs (Figure 19 F). These findings indicate that in addition to CRAC-mediated 
Ca2+ signaling, the cytokine production upon histamine stimulation is dependent on other 







Figure 18. CRAC channel blockers attenuate histamine-induced hyperpermeability 
and VE-cadherin disruption in HDLECs.  
A. The FITC-dextran fluorescence density in the lower chamber of each group was 
measured, normalized to that of the untreated control group, and summarized in the bar 
graph. B. TEER values of the HDLEC monolayer in each group were measured at 
indicated time points and normalized to the basal value at time 0. Values from at least 
three biological replicates were averaged for each group. C – N. Representative confocal 
immunofluorescence images showed VE-cadherin and DAPI staining in the HDLEC 
monolayer of each group. VE-cadherin and DAPI are displayed in red and blue, 
respectively, in the merged images on the right. The treatments are indicated on the left, 
VE-cadherin gaps are shown by yellow arrowheads, and the scale bar is 20 µm. 
Statistically significant differences are indicated by different letters from a to c. Ctrl: 













Figure 19. Orai1 or STIM1 knockdown prevents the histamine-induced 
upregulation of IL-6, IL-8, but not SCF, in HDLECs.  
A – C. Quantitative RT-PCR analysis of mRNAs for IL-6 (A), IL-8 (B), and SCF (C) 
after histamine treatment for 2, 4, and 6 hours in HDLECs. GAPDH was used as the 
reference gene and all expressions are normalized to the basal expressions at time 0 
(untreated control). D – F. Quantitative RT-PCR results of mRNAs for IL-6 (D) IL-8 
(E), and SCF (F) two hours after histamine treatment in untreated control cells, Orai1-
knockdown cells, and STIM1-knockdown cells. *: P < 0.05 compared to the untreated 
control in Student's t-tests. Statistical significance in Tukey’s HSD test is indicated by 






The lymphatic system is a key pathway for the transport of antigens and 
lymphocytes from the tissue to the lymphatic nodes, and hence, regarded as a vital part 
of immune initiation and maintenance (2, 25, 175, 176, 242). Therefore, it is closely 
associated with numerous pathological conditions involving inflammation, including 
infection, allergy, IBD, rheumatoid arthritis, and wound healing (22, 37, 214, 215, 243-
246). How the lymphatics regulates their vascular functions and immune responses in 
inflammatory conditions is now an emerging field of research (2, 22, 25, 37). Histamine 
is an inflammatory mediator widely used in the studies of in vivo and in vitro responses 
to inflammatory stimuli, and Ca2+ signaling is critical for histamine responses in various 
cell types (59, 60). However, the Ca2+ channels mediating this Ca2+ signaling and their 
functions in downstream cellular responses remain to be explored in the lymphatics. In 
this study, we showed that CRAC channels conduct the histamine-elicited Ca2+ entry and 
are necessary for the hyperpermeability as well as interleukin production following 
histamine stimulation in HDLECs. The essential role of CRAC channels in Ca2+ 
homeostasis and signaling has been shown in the immune cells and various other cell 
types or tissues (90, 125, 126, 187, 188, 247, 248). However, this is the first time that 
CRAC channels have been demonstrated to be required for the lymphatic endothelial 
response to histamine stimulation. Our findings suggest a critical contribution of CRAC 
channels in mediating inflammatory responses in the lymphatic endothelium and a 




Utilizing pharmacological inhibitors, we demonstrated that histamine activates 
the PLC family after binding to the H1R and triggers the intracellular Ca2+ store release 
followed by a sustained extracellular Ca2+ entry through CRAC channels in LECs. Our 
RNAi results provided further support that the endogenous CRAC channel components, 
Orai1 and STIM1, are indispensable for the Ca2+ influx into HDLECs upon histamine 
stimulation, indicating a unique function of CRAC channels in maintaining prolonged 
Ca2+ signaling in histamine-related inflammatory conditions. Notably, the ability for 
some intracellular Ca2+ store release remained after CRAC channel blockage. Thus, 
CRAC channels probably have a limited effect on those cellular functions only requiring 
a transient and relatively small Ca2+ signal to initiate. However, CRAC channels are vital 
for refilling the intracellular Ca2+ store, and hence, may be necessary for frequent or 
prolonged stimulation.  
Histamine is well known to disrupt blood vascular barrier functions, especially in 
the microvasculature, during infection and allergy (59, 61, 237). A recent study showed 
that inflammatory mediators, histamine and thrombin, were also able to decrease the 
barrier function of cultured LECs, which is modulated by Rho kinase (ROCK) and 
cyclic adenosine monophosphate (cAMP) (219). Our present data provide the first link 
of the histamine-triggered endothelial hyperpermeability and adherens junction 
disruption to the Ca2+ signaling via CRAC channels, shedding light into the mechanism 
of how lymphatic vessels regulate the barrier functions upon inflammatory stimulations. 
VE-cadherin is a key component of adherens junctions connected to actin or actomyosin 




proposed to be responsible for compromised VE-cadherin stability and eventually 
enhanced vascular permeability, including but not limited to phosphorylation, 
internalization, enzymatic cleavage, and cellular retraction (239, 249). Ca2+ signaling is 
one of the most prominent intracellular pathways regulating VE-cadherin functions as 
shown by studies on VE-cadherin phosphorylation and actin-myosin contraction in 
BECs (65, 238, 249, 250). Here, we provide evidence for the function of CRAC-
mediated Ca2+ signaling in LECs responding to histamine, indicating a novel potential 
target to treat pathological disorders involving increased lymphatic vascular permeability 
triggered by inflammatory mediators. Notably, because histamine-triggered lymphatic 
hyperpermeability could possibly weaken the lymphatic drainage of tissue fluid and 
worsen local swelling, anti-histamine medications may reduce lymph leakage and 
attenuate lymphedema caused by infection or inflammation. 
The lymphatics recruit and transport leukocytes to the lymph nodes after they 
interact with antigens in infected or injured tissues, maintaining the proper immune 
surveillance (2, 25).  This process is under dynamic control of cytokine/chemokine 
production and chemoattraction. LECs express various cytokines/chemokines, including 
IL-6, IL-8, and SCF, to recruit leukocytes and enhance EC-leukocyte interaction during 
inflammation (251-258). Our results demonstrated significant increases in the 
transcription of IL-6, IL-8, and SCF after histamine stimulation and showed that 
expression of IL-6 and IL-8 is dependent on CRAC channel function, suggesting a 
possible approach to regulate interleukin production and LEC-leukocyte interaction in 




significantly affected by CRAC blockage, implying other intracellular signaling are also 
involved in modulating the transcriptional reprograming after histamine stimulation. 
Overall, our data demonstrate the essential role of CRAC channels, formed by 
Orai1 and STIM1, in mediating histamine-evoked Ca2+ signaling and further alterations 
in barrier function and interleukin expression in LECs. These findings pave the way 
toward understanding lymphatic responses to inflammatory stimuli and developing 











The lymphatic system, compared with the blood circulation, is largely neglected 
in the research field, regardless of its fundamental role in maintaining body fluid 
homeostasis, immune surveillance, and dietary lipid absorption (259). Lymphatic 
pumping generates the force needed to drive fluid, proteins, and lipids toward the 
systemic circulation; meanwhile, the lymphatics transport antigens and lymphocytes 
from the tissue to the lymphatic nodes and, hence, are regarded as a vital part of the 
initiation and maintenance of immune responses (2, 5, 12, 25, 175, 176, 242). The 
deficient action of CRAC channels in the lymphatic system has been intensely studied in 
lymphocytes. The diminished ICRAC caused by an Orai1 mutation, R91W, in SCID 
patients leads to significantly impaired T cell activation and NFAT-dependent gene 
expressions (90). Additionally, abolished expression of Orai1 proteins by Orai1 
mutations, A88SfsX25, A103E, and L194P, also remarkably impaired the activation and 
proliferation of lymphocytes, including T cells and B cells, in patients with 
immunodeficiency (126). Consistent with the observations in human patients, Orai1 was 
intensely expressed in thymus, lymph nodes, and lymphocytes in wild-type C57BL/6 
mice (146). Compared with the wild-type mice, Orai1 global knockout mice displayed 
significant reductions of ICRAC in lymphocytes and showed perinatal lethality. After 
backcrossing to the outbred ICR mouse strain, the surviving Orai1-deficient mice 




lymphadenopathy, and decreased cytokine production by lymphocytes (146). Similar to 
the Orai1 defects, loss of functional STIM1, due to a mutation (E136X) causing a 
premature termination of STIM1 proteins, also led to lymphadenopathy and 
hepatosplenomegaly in human patients (129). Comparably, CD4+ T cell-specific STIM1 
and STIM2 double knockout mice showed notable splenomegaly, lymphadenopathy, 
leukocyte infiltration in the lungs and livers, and fewer Tregs in the spleen and lymph 
nodes (108). Taken together, these observations indicate CRAC channels have vital roles 
in lymphocyte activation and cytokine production; lacking functional CRAC channels 
may lead to severe lymphoid defects and immune deficiency.  
However, the role of the CRAC channel in the lymphatic system, especially in 
LECs, is still largely unknown, despite the emerging functions of LECs in modulating 
the adaptive immune responses. It is well established that LECs recruit DCs, T-cells, and 
other immune cells, and modulate their trafficking/entry into the lymph nodes by 
producing a set of chemokines (e.g., CCL1, 2, 5, 7, 21 and CXCL1, 3, 5, 6, 8) (2, 260-
263). In addition, LECs express multiple cell-cell adhesion molecules to facilitate 
leukocyte interaction and transmigration into the lymphatic vessels (9, 220). 
Intriguingly, LECs are also capable of presenting antigens and modulating T-cell 
functions directly via the major histocompatibility complex (MHC) class I and II on the 
cell surface (37, 264, 265). Furthermore, LECs can regulate T-cell homeostasis by 
producing IL-7, and influence T-cell activation by binding to DCs through intercellular 
adhesion molecule 1 (ICAM1) (266-269). Last but not least, LECs produce various 




immune responses dynamically (2, 37, 246, 263). Considering the role of LECs in the 
immune responses, it is possible that impaired CRAC channel activity in LECs may 
compromise the LEC functions responding to external stimuli and, therefore, 
contributing to the immunodeficiency in the human patients and genetically modified 
mouse models. In this dissertation, we present data that show CRAC channels are 
required for the Ca2+ signaling and downstream cytokine production in LECs, 
responding to FSS and histamine, emphasizing the importance of CRAC channels in the 
LEC-dependent regulation of inflammation and immune functions. 
Lymphatic endothelium, the inner layer of the lymphatic vessel wall, is directly 
subjected to lymph flow and plays a critical role in regulating lymphatic functions based 
on the FSS and pressure (42, 43, 54, 56, 270). We have demonstrated the pattern and 
sources of FSS-induced Ca2+ dynamics in LECs and discovered that they are sensitive to 
a CRAC channel blocker, Synta66 (165). Others found that Orai1 mediated the laminar 
flow-dependent Ca2+ influx, LEC proliferation, and lymphatic spouting (166, 167). 
Nevertheless, the specific role of CRAC channels in the FSS-elicited Ca2+ signaling in 
LECs and the participating channel molecules have not been thoroughly studied. In this 
dissertation research, we determined that FSS evokes CRAC-mediated Ca2+ mobilization 
followed by ER Ca2+ store release in LECs, and the fundamental channel molecules 
behind this process are Orai1 and STIM1. We further ruled out the major involvement of 
Piezo proteins and TRPV4 channels, but found a marginal function of purinoceptors in 
this FSS-induced Ca2+ responses. We also found CRAC-dependent NFAT translocation 




regulation, we observed an anti-inflammatory effect of FSS due to the downregulation 
pro-inflammatory cytokines/chemokines and the upregulation anti-inflammatory 
cytokines. Utilizing qRT-PCR and ELISA, we confirmed that IL-8, a major pro-
inflammatory cytokine produced by LECs, is significantly reduced by FSS in a CRAC-
dependent manner. 
In addition to mechanical forces, LECs are also exposed to many inflammatory 
factors and participate in modulating the local inflammation by producing and secreting 
cytokines to attract and interact with leukocytes (25, 44, 220, 271, 272). Histamine is a 
widely-studied inflammatory mediator involved in various immune responses (e.g., 
infections and allergies) (59). In BECs, histamine has an acute effect (within minutes) of 
disrupting the endothelial barrier function following Ca2+ mobilization and MLC 
phosphorylation (62, 67). At later stages (in hours), histamine induces the expression of 
IL-6 and IL-8 in a dose-dependent manner in HUVECs (71, 72). Our group previously 
reported that the CRAC channel was responsible for the histamine-induced Ca2+ entry, 
downstream NFAT translocation, and IL-8 expression in HUVECs (164). However, the 
effects of histamine in the lymphatic system have been largely overlooked. Recently, 
cAMP and ROCK were shown to inhibit histamine-induced LEC hyperpermeability 
(219). Another study found that histamine is involved in the flow-dependent lymphatic 
vessel relaxation (58). Despite the vital role of Ca2+ signaling in the histamine responses, 
the Ca2+ dynamics and conducting channels have not been studied in LECs upon 
histamine stimulation. In this dissertation, we described the Ca2+ mobilization triggered 




Ca2+ response to H1R antagonists, PLC inhibitors, CRAC channel blockers, and 
extracellular Ca2+ sources. These results suggest that histamine binds to H1R and 
activates PLC to release the ER Ca2+ stores, which evokes CRAC-mediated SOCE from 
the external environment into LECs. We further identified Orai1 and STIM1 to be the 
basic channel molecules for this Ca2+ entry, emphasizing the essential role of the CRAC 
channels in this process. In the downstream effects, the CRAC channel is required for 
histamine-induced VE-cadherin disruption, LEC hyperpermeability, and the production 
of IL-6 and IL-8. In summary, CRAC channels mediate histamine-evoked Ca2+ entry, 
barrier disruption, and cytokine production in LECs. 
Unlike the blood circulation, the lymphatic system is blind-ended and does not 
have a heart to generate the force to drive lymph flow forward (2). Instead, the lymphatic 
vessels transport the lymph via the phasic and tonic contractions of the lymphangion and 
minimize the backflow with lymphatic valves (5, 10). The distinct features of force 
generation lead to completely different flow patterns in the bloodstream and the 
lymphatics (5, 10, 11, 41, 177). The flow is laminar and steady (>12 dyn/cm2) in most 
regions of blood vessels, except for branching and curving areas where flow is lower and 
disturbed (± 4 dyn/cm2) (273, 274). Many studies have discovered remarkably different 
responses to these two flow patterns in BECs: the disturbed flow induces a pro-
inflammatory environment through apoptosis signal-regulating kinase 1 (ASK1) and c-
Jun NH2-terminal kinase (JNK), while steady laminar flow prevents the inflammation 
and protects the BECs via KLF2 and nuclear factor erythroid 2-like 2 (Nrf2) (274). On 




even be bi-directional near the valve (5, 11, 41, 177). Based on the data collected from 
rat mesenteric collecting lymphatics, the average FSS is approximately 0.4-0.6 dyn/cm2, 
while the peak FSS can be 3-10 dyn/cm2 (5). Given the unique flow pattern in the 
lymphatics, LECs are possibly more sensitive to low FSS and better adapted to disturbed 
flow, compared to BECs. To better characterize the FSS responses in LECs, we 
demonstrated that 4 dyn/cm2 or lower FSS is sufficient to evoke significant CRAC-
dependent Ca2+ dynamics in LECs and trigger downstream transcriptional regulation. 
Intriguingly, the FSS displays a “protective” effect by inducing the expression of anti-
inflammatory cytokines as well as KLF2, 4, and 10, while downregulating the 
expression of pro-inflammatory cytokines in LECs. Furthermore, blockage of CRAC 
channels partially reverses this effect, which is also supported by our qRT-PCR and 
ELISA data of IL-8 production. In other words, these data support the idea that lymph 
flow helps to maintain the LECs at a resting status, while losing the FSS stimuli or key 
components of the mechanotransduction pathway (e.g., CRAC channel) triggers 
inflammatory responses in LECs. In lymphedema involving lymphatic obstruction or 
dysfunction, inflammation is commonly observed and primarily caused by the 
accumulation of macrophages and pro-inflammatory factors (23, 24, 244). Our data 
provide critical evidence that lacking flow/FSS stimuli increases the expression of pro-
inflammatory cytokines and chemokines in LECs, and possibly contributes to the initial 
development of local inflammation. However, given that LECs are quite different from 




effect of FSS in LECs is “protective”, as it is in BECs, remains to be elucidated in 
further investigations. 
Histamine has been shown to lower blood pressure, dilate and transiently 
permeabilize blood capillaries, and induce interleukin expression in HUVECs (60, 73). 
Although the histamine-triggered hyperpermeability is a vital factor causing allergy and 
asthma, the molecular mechanism behind this process is still incompletely understood 
(69, 275, 276). Many studies reveal that the compromised barrier function after 
histamine stimulation results from disruption of intercellular junctions, including 
adherens and tight junctions (63-65, 68, 69, 277, 278). Ca2+ signaling, Rho family 
proteins, MLCK, and cAMP contribute to the formation of intercellular gaps, yet, the 
detailed signaling pathways are under debate (65, 68, 69, 249, 250, 278, 279). In the 
lymphatic system, the adhesive cell-to-cell junctions are specialized to meet the 
functions in different regions. The junctions are continuous and “zipper-like” in the 
collecting lymphatics, which are more similar to the blood vasculature, while the 
junctions are discontinuous and “bottom-like” in the initial lymphatics, which are more 
permeable to macromolecules and cells (9, 280). Breslin showed that inflammatory 
mediators, histamine and thrombin, disrupted lymphatic barrier function in a different 
manner compared with that in the blood endothelium (219). We provide evidence in this 
dissertation that Ca2+ entry via the CRAC channels is critical to the histamine-induced 
VE-cadherin disruption and barrier function of LECs. Specifically, we observed that 
histamine enhanced the permeability of the LEC monolayer using two different methods, 




assay evaluates the barrier function of cultured LECs to macromolecules (~40 kDa), 
which mimics the paracellular leakage of albumin and other proteins (239, 281). On the 
other hand, the TEER method measures the ionic conductance of the cell monolayer, 
which represents the integrity of intercellular adhesive junctions and the permeability to 
small electrolytes (282). Our data demonstrate that CRAC blockage completely prevents 
the macromolecule leakage caused by histamine in the Transwell® assay, while partially 
inhibiting the increased small electrolytes movement induced by histamine in TEER 
measurements. This result suggests that the CRAC channels play a dominant role in 
macromolecule permeability but only a partial role in small particle permeability in the 
LEC monolayer. The confocal images of VE-cadherin show that blocking CRAC 
channels prevents the majority of VE-cadherin disruption induced upon histamine 
stimulation, which again supports our permeability measurement data.  
Over the past decade, the functional role of  the lymphatic system in 
inflammatory diseases, adaptive immunity, and immune tolerance has become an 
emerging area of study (2, 22, 25, 37, 175, 259, 283). Especially, the immunomodulatory 
function of LECs is more accepted and focused, because LECs are closely involved in 
antigen presentation, leukocyte activation, as well as lymphocyte transportation (220, 
283, 284). In this dissertation, we demonstrate that Ca2+ entry conducted by the CRAC 
channels is critical for LECs responding to both a mechanical stimulus (FSS) and an 
inflammatory mediator (histamine). The CRAC channels are required for mediating 
sustained Ca2+ signaling that triggers the downstream cellular functions (e.g., 




production) in LECs. Most intriguingly, the CRAC channel contributes to the regulation 
of interleukin expression/secretion under both conditions (FSS and histamine stimuli), 
highlighting its crucial role in the immunomodulatory function of LECs. 
 
4.2. Limitations of this study and future directions 
In order to study the Ca2+ mobilization and cellular functions in LECs, we 
utilized three different batches of HDLECs that are isolated from juvenile human 
foreskin and commercially available at PromoCell. The lymphatic vessels in the skin 
include initial lymphatics and pre-collecting lymphatics and, therefore, the HDLEC line 
is a mixture of LECs from these different vessels. Since the data collected from different 
batches of HDLECs are stable and consistent in the early passages (passage 3-9), our 
results in this dissertation represent a reliable readout regarding the function of capillary 
and pre-collecting LECs responding to FSS and histamine. However, these conclusions 
should not be directly applied to the LECs from other sections of lymphatic vessels (e.g., 
the collecting lymphatic vessels and lymphatic ducts). The LECs from other regions of 
lymphatic vessels may present similar properties due to the similarity of these LECs, yet 
it would not be surprising if they display different features, considering the fact that the 
LECs in the initial lymphatics are quite unique in terms of functions and structures, and 
are not identical to the LECs in other regions of lymphatic vessels. To better study the 
cellular functions in LECs from different regions of lymphatic vessels, tissue-specific or 




better understand the pathogenesis of lymphatic diseases, LEC lines are also needed 
from related patients at different ages and pathological stages.  
As discussed above, lymph flow is extremely dynamic and varies from different 
regions of the body and in different parts of the lymphatic system (5, 10, 18, 38, 41, 
177). The amplitude and direction of lymph flow can change dramatically or even be 
transiently opposite in the pumping collecting lymphatics (1, 5, 41). We used FSS to 
study the Ca2+ signaling and downstream pathways in LECs. The flow developed in the 
orbital shaker has a relatively low and disturbed FSS in the center, with a higher and 
more laminar FSS in the peripheral regions (285, 286). The FSS has some features that 
resemble the physiological lymphatic FSS, yet, it still cannot mimic lymph FSS in many 
aspects. A better way of studying lymph flow in cultured LECs is to record the flow 
pattern in the lymphatic vessel of interest in vivo, and then, mimic the flow in a 
computer-controlled perfusion system. In addition, the genetically-modified animal 
model expressing genetically encoded calcium indicators (e.g., GCaMPs) in LECs is 
also a promising option to study the Ca2+ signaling in vivo or ex vivo in future studies. 
Taken together, the data in this dissertation emphasize the crucial role of CRAC 
channels in the Ca2+ signaling and downstream cell functions responding to FSS and 
histamine in LECs. Our results shed light on the cellular and molecular mechanisms 
behind the LEC-dependent regulation of lymphatic functions. Future investigations are 
still needed to further identify other participating factors in mechanotransduction and 
inflammatory responses in LECs. Moreover, the validation of these signaling pathways 
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